{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:51:33Z","timestamp":1794711093334,"version":"4.9.1"},"reference-count":452,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnologia","doi-asserted-by":"publisher","award":["738774"],"award-info":[{"award-number":["738774"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnologia","doi-asserted-by":"publisher","award":["857735"],"award-info":[{"award-number":["857735"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with increased prevalence\nand incidence in recent decades. Its etiology remains largely unclear, but it seems to involve a\nstrong genetic component and environmental factors that, in turn, induce epigenetic changes during\nembryonic and postnatal brain development. In recent decades, clinical studies have shown that inutero\nexposure to valproic acid (VPA), a commonly prescribed antiepileptic drug, is an environmental\nfactor associated with an increased risk of ASD. Subsequently, prenatal VPA exposure in rodents has\nbeen established as a reliable translational model to study the pathophysiology of ASD, which has\nhelped demonstrate neurobiological changes in rodents, non-human primates, and brain organoids\nfrom human pluripotent stem cells. This evidence supports the notion that prenatal VPA exposure is a\nvalid and current model to replicate an idiopathic ASD-like disorder in experimental animals. This review\nsummarizes and describes the current features reported with this animal model of autism and the\nmain neurobiological findings and correlates that help elucidate the pathophysiology of ASD. Finally,\nwe discuss the general framework of the VPA model in comparison to other environmental and genetic\nASD models.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x22666231003121513","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T11:53:22Z","timestamp":1697543602000},"page":"260-289","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Three Decades of Valproate: A Current Model for Studying Autism\nSpectrum Disorder"],"prefix":"10.2174","volume":"22","author":[{"given":"David","family":"Zarate-Lopez","sequence":"first","affiliation":[{"name":"Laboratory of Neuroscience, School of Psychology, University of Colima, Colima 28040, M\u00e9xico"},{"name":"Physiological Science Ph.D. Program, School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Laura","family":"Torres-Ch\u00e1vez","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroscience, School of Psychology, University of Colima, Colima 28040, M\u00e9xico"},{"name":"Physiological Science Ph.D. Program, School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma Yadira","family":"G\u00e1lvez-Contreras","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Centro Universitario de Ciencias de la Salud, University of Guadalajara, Guadalajara 44340, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Gonzalez-Perez","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroscience, School of Psychology, University of Colima, Colima 28040, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","volume":"392","author":"Lord C.","year":"2018","unstructured":"Lord C.; Elsabbagh M.; Baird G.; Veenstra-Vanderweele J.; Autism spectrum disorder. Lancet 2018,392(10146),508-520","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"972809","DOI":"10.3389\/fped.2022.972809","volume":"10","author":"Li Y.A.","year":"2022","unstructured":"Li Y.A.; Chen Z.J.; Li X.D.; Gu M.H.; Xia N.; Gong C.; Zhou Z.W.; Yasin G.; Xie H.Y.; Wei X.P.; Liu Y.L.; Han X.H.; Lu M.; Xu J.; Huang X.L.; Epidemiology of autism spectrum disorders: Global burden of disease 2019 and bibliometric analysis of risk factors. Front Pediatr 2022,10,972809","journal-title":"Front Pediatr"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.05.007","volume":"190","author":"Sharma S.R.","year":"2018","unstructured":"Sharma S.R.; Gonda X.; Tarazi F.I.; Autism spectrum disorder: Classification, diagnosis and therapy. Pharmacol Ther 2018,190,91-104","journal-title":"Pharmacol Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00018-018-2988-4","volume":"76","author":"B\u00f6lte S.","year":"2019","unstructured":"B\u00f6lte S.; Girdler S.; Marschik P.B.; The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci 2019,76(7),1275-1297","journal-title":"Cell Mol Life Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","volume":"6","author":"Lord C.","year":"2020","unstructured":"Lord C.; Brugha T.S.; Charman T.; Cusack J.; Dumas G.; Frazier T.; Jones E.J.H.; Jones R.M.; Pickles A.; State M.W.; Taylor J.L.; Veenstra-VanderWeele J.; Autism spectrum disorder. Nat Rev Dis Primers 2020,6(1),5","journal-title":"Nat Rev Dis Primers"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S1474-4422(15)00314-2","volume":"15","author":"Tomson T.","year":"2016","unstructured":"Tomson T.; Battino D.; Perucca E.; Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol 2016,15(2),210-218","journal-title":"Lancet Neurol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","volume":"9","author":"Johannessen C.U.","year":"2003","unstructured":"Johannessen C.U.; Johannessen S.I.; Valproate: Past, present, and future. CNS Drug Rev 2003,9(2),199-216","journal-title":"CNS Drug Rev"},{"key":"ref=8","author":"Rahman M.","year":"2022","unstructured":"Rahman M.; Nguyen H.;  Valproic Acid Available from:2022","journal-title":"Valproic Acid"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4236\/ojpsych.2023.132011","volume":"13","author":"Mohamed Z.A.","year":"2023","unstructured":"Mohamed Z.A.; Thokerunga E.; Jimale A.O.; Liu Z.; Fan J.; Risk of autism spectrum disorder according to the dose and trimester of exposure to antiseizure medications: A systematic review and meta-analysis. Open J Psychiatr 2023,13(2),106-121","journal-title":"Open J Psychiatr"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"821455","DOI":"10.3389\/fpsyt.2022.821455","volume":"13","author":"Sato A.","year":"2022","unstructured":"Sato A.; Kotajima-Murakami H.; Tanaka M.; Katoh Y.; Ikeda K.; Influence of prenatal drug exposure, maternal inflammation, and parental aging on the development of autism spectrum disorder. Front Psychiatry 2022,13,821455","journal-title":"Front Psychiatry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41378-020-0165-z","volume":"6","author":"Cui K.","year":"2020","unstructured":"Cui K.; Wang Y.; Zhu Y.; Tao T.; Yin F.; Guo Y.; Liu H.; Li F.; Wang P.; Chen Y.; Qin J.; Neurodevelopmental impairment induced by prenatal valproic acid exposure shown with the human cortical organoid-on-a-chip model. Microsyst Nanoeng 2020,6(1),49","journal-title":"Microsyst Nanoeng"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1023765","DOI":"10.3389\/fnmol.2022.1023765","volume":"15","author":"Zang Z.","year":"2022","unstructured":"Zang Z.; Yin H.; Du Z.; Xie R.; Yang L.; Cai Y.; Wang L.; Zhang D.; Li X.; Liu T.; Gong H.; Gao J.; Yang H.; Warner M.; Gustafsson J.A.; Xu H.; Fan X.; Valproic acid exposure decreases neurogenic potential of outer radial glia in human brain organoids. Front Mol Neurosci 2022,15,1023765","journal-title":"Front Mol Neurosci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41398-022-01898-x","volume":"12","author":"Meng Q.","year":"2022","unstructured":"Meng Q.; Zhang W.; Wang X.; Jiao C.; Xu S.; Liu C.; Tang B.; Chen C.; Human forebrain organoids reveal connections between valproic acid exposure and autism risk. Transl Psychiatry 2022,12(1),130","journal-title":"Transl Psychiatry"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0099-5428(08)60128-8","author":"Chang Z.L.","year":"1979","unstructured":"Chang Z.L.; Sodium valproate and valproic acid. Analytical Profiles of Drug Substances 1979,529-556","journal-title":"Analytical Profiles of Drug Substances"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","volume":"23","author":"Ghodke-Puranik Y.","year":"2013","unstructured":"Ghodke-Puranik Y.; Thorn C.F.; Lamba J.K.; Leeder J.S.; Song W.; Birnbaum A.K.; Altman R.B.; Klein T.E.; Valproic acid pathway. Pharmacogenet Genomics 2013,23(4),236-241","journal-title":"Pharmacogenet Genomics"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bcp.13510","volume":"84","author":"Methaneethorn J.","year":"2018","unstructured":"Methaneethorn J.; A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol 2018,84(5),816-834","journal-title":"Br J Clin Pharmacol"},{"key":"ref=17","first-page":"5","volume":"37","author":"Henry T.R.","year":"2003","unstructured":"Henry T.R.; The history of valproate in clinical neuroscience. Psychopharmacol Bull 2003,37(S2),5-16","journal-title":"Psychopharmacol Bull"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","volume":"17","author":"Romoli M.","year":"2019","unstructured":"Romoli M.; Mazzocchetti P.; D\u2019Alonzo R.; Siliquini S.; Rinaldi V.E.; Verrotti A.; Calabresi P.; Costa C.; Valproic acid and epilepsy: From molecular mechanisms to clinical evidences. Curr Neuropharmacol 2019,17(10),926-946","journal-title":"Curr Neuropharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2174\/1570159X21666230224102318","volume":"21","author":"Carli M.","year":"2023","unstructured":"Carli M.; Weiss F.; Grenno G.; Ponzini S.; Kolachalam S.; Vaglini F.; Viaggi C.; Pardini C.; Tidona S.; Longoni B.; Maggio R.; Scarselli M.; Pharmacological strategies for bipolar disorders in acute phases and chronic management with a special focus on lithium, valproic acid, and atypical antipsychotics. Curr Neuropharmacol 2023,21(4),935-950","journal-title":"Curr Neuropharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10194-008-0002-5","volume":"9","author":"Yurekli V.A.","year":"2008","unstructured":"Yurekli V.A.; Akhan G.; Kutluhan S.; Uzar E.; Koyuncuoglu H.R.; Gultekin F.; The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain 2008,9(1),37-41","journal-title":"J Headache Pain"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/ane.13325","volume":"142","author":"Wang F.","year":"2020","unstructured":"Wang F.; Zhang H.; Wang L.; Cao Y.; He Q.; Intravenous sodium valproate for acute migraine in the emergency department: A meta\u2010analysis. Acta Neurol Scand 2020,142(6),521-530","journal-title":"Acta Neurol Scand"},{"key":"ref=22","first-page":"CD004028","volume":"11","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; Xia J.; Helfer B.; Li C.; Leucht S.; Valproate for schizophrenia. Cochrane Database Syst Rev 2016,11(11),CD004028","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=23","first-page":"768","volume":"219","author":"Nau H.","year":"1981","unstructured":"Nau H.; Rating D.; Koch S.; H\u00e4user I.; Helge H.; Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother\u2019s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 1981,219(3),768-777","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5487\/TR.2010.26.4.275","volume":"26","author":"Jeong E.J.","year":"2010","unstructured":"Jeong E.J.; Yu W.J.; Kim C.Y.; Chung M.K.; Placenta transfer and toxicokinetics of valproic acid in pregnant cynomolgus monkeys. Toxicol Res 2010,26(4),275-283","journal-title":"Toxicol Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5487\/TR.2013.29.1.053","volume":"29","author":"Lee J.H.","year":"2013","unstructured":"Lee J.H.; Yu W.J.; Jeong E.J.; Chung M.K.; Milk transfer and toxicokinetics of valproic Acid in lactating cynomolgus monkeys. Toxicol Res 2013,29(1),53-60","journal-title":"Toxicol Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002018-200629010-00001","volume":"29","author":"Genton P.","year":"2006","unstructured":"Genton P.; Semah F.; Trinka E.; Valproic acid in epilepsy: Pregnancy-related issues. Drug Saf 2006,29(1),1-21","journal-title":"Drug Saf"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","volume":"43","author":"Williams G.","year":"2001","unstructured":"Williams G.; King J.; Cunningham M.; Stephan M.; Kerr B.; Hersh J.H.; Fetal valproate syndrome and autism: Additional evidence of an association. Dev Med Child Neurol 2001,43(3),202-206","journal-title":"Dev Med Child Neurol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0012162205001076","volume":"47","author":"Rasalam A.D.","year":"2005","unstructured":"Rasalam A.D.; Hailey H.; Williams J.H.G.; Moore S.J.; Turnpenny P.D.; Lloyd D.J.; Dean J.C.S.; Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005,47(8),551-555","journal-title":"Dev Med Child Neurol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","volume":"28","author":"Ornoy A.","year":"2009","unstructured":"Ornoy A.; Valproic acid in pregnancy: How much are we endangering the embryo and fetus? Reprod Toxicol 2009,28(1),1-10","journal-title":"Reprod Toxicol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5698\/1535-7597-13.6.282","volume":"13","author":"Harden C.L.","year":"2013","unstructured":"Harden C.L.; In utero valproate exposure and autism: Long suspected, finally proven. Epilepsy Curr 2013,13(6),282-284","journal-title":"Epilepsy Curr"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"Christensen J.","year":"2013","unstructured":"Christensen J.; Gr\u00f8nborg T.K.; S\u00f8rensen M.J.; Schendel D.; Parner E.T.; Pedersen L.H.; Vestergaard M.; Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013,309(16),1696-1703","journal-title":"JAMA"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.epilep.2013.01.002","volume":"1","author":"Elger C.E.","year":"2013","unstructured":"Elger C.E.; Is valproate contraindicated in young women with epilepsy? No. Epileptology 2013,1(1),43-45","journal-title":"Epileptology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12884-018-1842-x","volume":"18","author":"Macfarlane A.","year":"2018","unstructured":"Macfarlane A.; Greenhalgh T.; Sodium valproate in pregnancy: What are the risks and should we use a shared decision-making approach? BMC Pregnancy Childbirth 2018,18(1),200","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/adc.69.3_Spec_No.288","volume":"69","author":"Thisted E.","year":"1993","unstructured":"Thisted E.; Ebbesen F.; Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child 1993,69,288-291","journal-title":"Arch Dis Child"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-0043-107619","volume":"221","author":"Wiedemann K.","year":"2017","unstructured":"Wiedemann K.; St\u00fcber T.; Rehn M.; Frieauff E.; Fetal valproate syndrome - still a problem today! Z Geburtshilfe Neonatol 2017,221(5),243-246","journal-title":"Z Geburtshilfe Neonatol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/BF02859291","volume":"73","author":"Kulkarni M.L.","year":"2006","unstructured":"Kulkarni M.L.; Zaheeruddin M.; Shenoy N.; Vani H.N.; Fetal valproate syndrome. Indian J Pediatr 2006,73(10),937-939","journal-title":"Indian J Pediatr"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/0971-6866.142898","volume":"20","author":"Chandane P.","year":"2014","unstructured":"Chandane P.; Shah I.; Fetal valproate syndrome. Indian J Hum Genet 2014,20(2),187-188","journal-title":"Indian J Hum Genet"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/0256-4947.62839","volume":"30","author":"Zaki S.A.","year":"2010","unstructured":"Zaki S.A.; Phulsundar A.; Shanbag P.; Mauskar A.; Fetal valproate syndrome in a 2-month-old male infant. Ann Saudi Med 2010,30(3),233-235","journal-title":"Ann Saudi Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/epi.13007","volume":"56","author":"Wood A.G.","year":"2015","unstructured":"Wood A.G.; Nadebaum C.; Anderson V.; Reutens D.; Barton S.; O\u2019Brien T.J.; Vajda F.; Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy. Epilepsia 2015,56(7),1047-1055","journal-title":"Epilepsia"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/adc.2009.176990","volume":"96","author":"Cummings C.","year":"2011","unstructured":"Cummings C.; Stewart M.; Stevenson M.; Morrow J.; Nelson J.; Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011,96(7),643-647","journal-title":"Arch Dis Child"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1212\/WNL.0b013e3182088297","volume":"76","author":"Shallcross R.","year":"2011","unstructured":"Shallcross R.; Bromley R.L.; Irwin B.; Bonnett L.J.; Morrow J.; Baker G.A.; Child development following in utero exposure: Levetiracetam vs sodium valproate. Neurology 2011,76(4),383-389","journal-title":"Neurology"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","volume":"360","author":"Meador K.J.","year":"2009","unstructured":"Meador K.J.; Baker G.A.; Browning N.; Clayton-Smith J.; Combs-Cantrell D.T.; Cohen M.; Kalayjian L.A.; Kanner A.; Liporace J.D.; Pennell P.B.; Privitera M.; Loring D.W.; Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009,360(16),1597-1605","journal-title":"N Engl J Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1017\/S1355617710001359","volume":"17","author":"Nadebaum C.","year":"2011","unstructured":"Nadebaum C.; Anderson V.; Vajda F.; Reutens D.; Barton S.; Wood A.; The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc 2011,17(1),133-142","journal-title":"J Int Neuropsychol Soc"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","volume":"76","author":"Nadebaum C.","year":"2011","unstructured":"Nadebaum C.; Anderson V.A.; Vajda F.; Reutens D.C.; Barton S.; Wood A.G.; Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011,76(8),719-726","journal-title":"Neurology"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/3495910","volume":"2016","author":"Goyal M.","year":"2016","unstructured":"Goyal M.; Gupta A.; Sharma M.; Mathur P.; Bansal N.; Fetal valproate syndrome with limb defects: An Indian case report. Case Rep Pediatr 2016,2016,1-4","journal-title":"Case Rep Pediatr"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","volume":"10","author":"Tomson T.","year":"2011","unstructured":"Tomson T.; Battino D.; Bonizzoni E.; Craig J.; Lindhout D.; Sabers A.; Perucca E.; Vajda F.; Dose-dependent risk of malformations with antiepileptic drugs: An analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011,10(7),609-617","journal-title":"Lancet Neurol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"c6581","DOI":"10.1136\/bmj.c6581","volume":"341","author":"Jentink J.","year":"2010","unstructured":"Jentink J.; Dolk H.; Loane MA.; Morris JK.; Wellesley D.; Garne E.; Intrauterine exposure to carbamazepine and specific congenital malformations: Systematic review and case-control study. BMJ 2010,341,c6581-c6581","journal-title":"BMJ"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/bdr2.1052","volume":"109","author":"Stadelmaier R.","year":"2017","unstructured":"Stadelmaier R.; Nasri H.; Deutsch C.K.; Bauman M.; Hunt A.; Stodgell C.J.; Adams J.; Holmes L.B.; Exposure to sodium valproate during pregnancy: Facial Features and Signs of Autism. Birth Defects Res 2017,109(14),1134-1143","journal-title":"Birth Defects Res"},{"key":"ref=49","author":"Donovan M.F.","year":"2023","unstructured":"Donovan M.F.; Cascella M.;  Embryology, Weeks 6-8StatPearls 2023","journal-title":"Embryology, Weeks 6-8StatPearls"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000289817","volume":"192","author":"O\u2019Rahilly R.","year":"2010","unstructured":"O\u2019Rahilly R.; M\u00fcller F.; Developmental stages in human embryos: Revised and new measurements. Cells Tissues Organs 2010,192(2),73-84","journal-title":"Cells Tissues Organs"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12884-017-1585-0","volume":"17","author":"Sass L.","year":"2017","unstructured":"Sass L.; Urhoj S.K.; Kj\u00e6rgaard J.; Dreier J.W.; Strandberg-Larsen K.; Nybo Andersen A.M.; Fever in pregnancy and the risk of congenital malformations: A cohort study. BMC Pregnancy Childbirth 2017,17(1),413","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1365-2125.2012.04286.x","volume":"74","author":"Rom\u00f8ren M.","year":"2012","unstructured":"Rom\u00f8ren M.; Lindbaek M.; Nordeng H.; Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. Br J Clin Pharmacol 2012,74(6),1053-1062","journal-title":"Br J Clin Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e0257584","DOI":"10.1371\/journal.pone.0257584","volume":"16","author":"Sun L.","year":"2021","unstructured":"Sun L.; Xi Y.; Wen X.; Zou W.; Use of metoclopramide in the first trimester and risk of major congenital malformations: A systematic review and meta-analysis. PLoS One 2021,16(9),e0257584","journal-title":"PLoS One"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","volume":"36","author":"Christianson A.L.","year":"1994","unstructured":"Christianson A.L.; Chester N.; Kromberg J.G.R.; Fetal valproate syndrome: Clinical and neuro-developmental features in two sibling pairs. Dev Med Child Neurol 1994,36(4),361-369","journal-title":"Dev Med Child Neurol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1055\/s-2008-1071520","volume":"24","author":"Laegreid L.","year":"1993","unstructured":"Laegreid L.; Kyllerman M.; Hedner T.; Hagberg B.; Viggedahl G.; Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy. Neuropediatrics 1993,24(2),88-92","journal-title":"Neuropediatrics"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","volume":"39","author":"Williams P.G.","year":"1997","unstructured":"Williams P.G.; Hersh J.H.; A male with fetal valproate syndrome and autism. Dev Med Child Neurol 1997,39(9),632-634","journal-title":"Dev Med Child Neurol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","volume":"71","author":"Bromley R.L.","year":"2008","unstructured":"Bromley R.L.; Mawer G.; Clayton-Smith J.; Baker G.A.; Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008,71(23),1923-1924","journal-title":"Neurology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/jmg.37.7.489","volume":"37","author":"Moore S.J.","year":"2000","unstructured":"Moore S.J.; Turnpenny P.; Quinn A.; Glover S.; Lloyd D.J.; Montgomery T.; Dean J.C.; A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000,37(7),489-497","journal-title":"J Med Genet"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/jmg.39.4.251","volume":"39","author":"Dean J.C.S.","year":"2002","unstructured":"Dean J.C.S.; Hailey H.; Moore S.J.; Lloyd D.J.; Turnpenny P.D.; Little J.; Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002,39(4),251-259","journal-title":"J Med Genet"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","volume":"84","author":"Bromley R.L.","year":"2013","unstructured":"Bromley R.L.; Mawer G.E.; Briggs M.; Cheyne C.; Clayton-Smith J.; Garc\u00eda-Fi\u00f1ana M.; Kneen R.; Lucas S.B.; Shallcross R.; Baker G.A.; Baker G.; Briggs M.; Bromley R.; Clayton-Smith J.; Dixon P.; Fryer A.; Gummery A.; Kneen R.; Kerr L.; Lucas S.; Mawer G.; Shallcross R.; The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013,84(6),637-643","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/CLEP.S118336","volume":"9","author":"Petersen I.","year":"2017","unstructured":"Petersen I.; Collings S.L.; McCrea R.L.; Nazareth I.; Osborn D.P.; Cowen P.J.; Sammon C.J.; Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: Comparative prevalence studies. Clin Epidemiol 2017,9,95-103","journal-title":"Clin Epidemiol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/pr.2018.23","volume":"84","author":"Hisle-Gorman E.","year":"2018","unstructured":"Hisle-Gorman E.; Susi A.; Stokes T.; Gorman G.; Erdie-Lalena C.; Nylund C.M.; Prenatal, perinatal, and neonatal risk factors of autism spectrum disorder. Pediatr Res 2018,84(2),190-198","journal-title":"Pediatr Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.31887\/DCNS.2012.14.3\/jcrawley","volume":"14","author":"Crawley J.N.","year":"2012","unstructured":"Crawley J.N.; Translational animal models of autism and neurodevelopmental disorders. Dialogues Clin Neurosci 2012,14(3),293-305","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=64","author":"Bauman M.D.","year":"2010","unstructured":"Bauman M.D.; Crawley J.N.; Berman R.F.;  Autism: Animal Models 2010","journal-title":"Autism: Animal Models"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-5380-1-9","volume":"1","author":"Belzung C.","year":"2011","unstructured":"Belzung C.; Lemoine M.; Criteria of validity for animal models of psychiatric disorders: Focus on anxiety disorders and depression. Biol Mood Anxiety Disord 2011,1(1),9","journal-title":"Biol Mood Anxiety Disord"},{"key":"ref=66","year":"2022","unstructured":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2022","journal-title":"Diagnostic and Statistical Manual of Mental Disorders"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","volume":"24","author":"Mabunga D.F.N.","year":"2015","unstructured":"Mabunga D.F.N.; Gonzales E.L.T.; Kim J.; Kim K.C.; Shin C.Y.; Exploring the validity of valproic acid animal model of autism. Exp Neurobiol 2015,24(4),285-300","journal-title":"Exp Neurobiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247:AID-CNE8>3.0.CO;2-2","volume":"370","author":"Rodier P.M.","year":"1996","unstructured":"Rodier P.M.; Ingram J.L.; Tisdale B.; Nelson S.; Romano J.; Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996,370(2),247-261","journal-title":"J Comp Neurol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"107477","DOI":"10.1016\/j.neuropharm.2018.12.024","volume":"159","author":"Tartaglione A.M.","year":"2019","unstructured":"Tartaglione A.M.; Schiavi S.; Calamandrei G.; Trezza V.; Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder. Neuropharmacology 2019,159,107477","journal-title":"Neuropharmacology"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"Nicolini C.","year":"2018","unstructured":"Nicolini C.; Fahnestock M.; The valproic acid-induced rodent model of autism. Exp Neurol 2018,299(Pt A),217-227","journal-title":"Exp Neurol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/7854_2015_404","author":"Ranger P.","year":"2015","unstructured":"Ranger P.; Ellenbroek B.A.; Perinatal influences of valproate on brain and behaviour: An animal model for autism. Neurotoxin Modeling of Brain Disorders\u2014Life-long Outcomes in Behavioral Teratology 2015,363-386","journal-title":"Neurotoxin Modeling of Brain Disorders\u2014Life-long Outcomes in Behavioral Teratology"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","volume":"36","author":"Roullet F.I.","year":"2013","unstructured":"Roullet F.I.; Lai J.K.Y.; Foster J.A.; In utero exposure to valproic acid and autism \u2014 A current review of clinical and animal studies. Neurotoxicol Teratol 2013,36,47-56","journal-title":"Neurotoxicol Teratol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","volume":"201","author":"Kim K.C.","year":"2011","unstructured":"Kim K.C.; Kim P.; Go H.S.; Choi C.S.; Yang S.I.; Cheong J.H.; Shin C.Y.; Ko K.H.; The critical period of valproate exposure to induce autistic symptoms in Sprague\u2013Dawley rats. Toxicol Lett 2011,201(2),137-142","journal-title":"Toxicol Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2008.01.055","volume":"1203","author":"Yochum C.L.","year":"2008","unstructured":"Yochum C.L.; Dowling P.; Reuhl K.R.; Wagner G.C.; Ming X.; VPA-induced apoptosis and behavioral deficits in neonatal mice. Brain Res 2008,1203,126-132","journal-title":"Brain Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2202-11-102","volume":"11","author":"Chomiak T.","year":"2010","unstructured":"Chomiak T.; Karnik V.; Block E.; Hu B.; Altering the trajectory of early postnatal cortical development can lead to structural and behavioural features of autism. BMC Neurosci 2010,11(1),102","journal-title":"BMC Neurosci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000336646","volume":"34","author":"Reynolds S.","year":"2012","unstructured":"Reynolds S.; Millette A.; Devine D.P.; Sensory and motor characterization in the postnatal valproate rat model of autism. Dev Neurosci 2012,34(2-3),258-267","journal-title":"Dev Neurosci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","volume":"36","author":"Wagner G.C.","year":"2006","unstructured":"Wagner G.C.; Reuhl K.R.; Cheh M.; McRae P.; Halladay A.K.; A new neurobehavioral model of autism in mice: Pre- and postnatal exposure to sodium valproate. J Autism Dev Disord 2006,36(6),779-793","journal-title":"J Autism Dev Disord"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2131\/jts.38.391","volume":"38","author":"Oguchi-Katayama A.","year":"2013","unstructured":"Oguchi-Katayama A.; Monma A.; Sekino Y.; Moriguchi T.; Sato K.; Comparative gene expression analysis of the amygdala in autistic rat models produced by pre- and post-natal exposures to valproic acid. J Toxicol Sci 2013,38(3),391-402","journal-title":"J Toxicol Sci"},{"key":"ref=79","first-page":"1","author":"Larner O.","year":"2021","unstructured":"Larner O.; Roberts J.; Twiss J.; Freeman L.;  A Need for consistency in behavioral phenotyping for ASD: Analysis of the valproic acid model Rossignol D 2021,1-10","journal-title":"A Need for consistency in behavioral phenotyping for ASD: Analysis of the valproic acid model Rossignol D"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000509109","volume":"42","author":"Chaliha D.","year":"2020","unstructured":"Chaliha D.; Albrecht M.; Vaccarezza M.; Takechi R.; Lam V.; Al-Salami H.; Mamo J.; A systematic review of the valproic-acid-induced rodent model of autism. Dev Neurosci 2020,42(1),12-48","journal-title":"Dev Neurosci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.stemcr.2015.10.012","volume":"5","author":"Juliandi B.","year":"2015","unstructured":"Juliandi B.; Tanemura K.; Igarashi K.; Tominaga T.; Furukawa Y.; Otsuka M.; Moriyama N.; Ikegami D.; Abematsu M.; Sanosaka T.; Tsujimura K.; Narita M.; Kanno J.; Nakashima K.; Reduced adult hippocampal neurogenesis and cognitive impairments following prenatal treatment of the antiepileptic drug valproic acid. Stem Cell Reports 2015,5(6),996-1009","journal-title":"Stem Cell Reports"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuroscience.2016.10.052","volume":"340","author":"Main S.L.","year":"2017","unstructured":"Main S.L.; Kulesza R.J.; Repeated prenatal exposure to valproic acid results in cerebellar hypoplasia and ataxia. Neuroscience 2017,340,34-47","journal-title":"Neuroscience"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuroscience.2017.12.053","volume":"372","author":"Cartocci V.","year":"2018","unstructured":"Cartocci V.; Catallo M.; Tempestilli M.; Segatto M.; Pfrieger F.W.; Bronzuoli M.R.; Scuderi C.; Servadio M.; Trezza V.; Pallottini V.; Altered brain cholesterol\/isoprenoid metabolism in a rat model of autism spectrum disorders. Neuroscience 2018,372,27-37","journal-title":"Neuroscience"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pnpbp.2018.02.008","volume":"84","author":"Cezar LC","year":"2018","unstructured":"Cezar LC; Kirsten TB; da Fonseca CCN; de Lima APN; Bernardi MM; Felicio LF; Zinc as a therapy in a rat model of autism prenatally induced by valproic acid. Prog Neuropsychopharmacol Biol Psychiatry 2018,84(Pt A),173-180","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fncel.2018.00355","volume":"12","author":"Dai Y.C.","year":"2018","unstructured":"Dai Y.C.; Zhang H.F.; Sch\u00f6n M.; B\u00f6ckers T.M.; Han S.P.; Han J.S.; Zhang R.; Neonatal oxytocin treatment ameliorates autistic-like behaviors and oxytocin deficiency in valproic acid-induced rat model of autism. Front Cell Neurosci 2018,12,355","journal-title":"Front Cell Neurosci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"e37313","DOI":"10.1371\/journal.pone.0037313","volume":"7","author":"Felix-Ortiz A.C.","year":"2012","unstructured":"Felix-Ortiz A.C.; Febo M.; Gestational valproate alters BOLD activation in response to complex social and primary sensory stimuli. PLoS One 2012,7(5),e37313","journal-title":"PLoS One"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbr.2013.09.049","volume":"257","author":"Moldrich R.X.","year":"2013","unstructured":"Moldrich R.X.; Leanage G.; She D.; Dolan-Evans E.; Nelson M.; Reza N.; Reutens D.C.; Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. Behav Brain Res 2013,257,253-264","journal-title":"Behav Brain Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1096\/fj.201700054R","volume":"31","author":"Kuo H.Y.","year":"2017","unstructured":"Kuo H.Y.; Liu F.C.; Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder. FASEB J 2017,31(10),4458-4471","journal-title":"FASEB J"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1111\/bph.14435","volume":"175","author":"Melancia F.","year":"2018","unstructured":"Melancia F.; Schiavi S.; Servadio M.; Cartocci V.; Campolongo P.; Palmery M.; Pallottini V.; Trezza V.; Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling. Br J Pharmacol 2018,175(18),3699-3712","journal-title":"Br J Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.euroneuro.2017.11.014","volume":"28","author":"Servadio M.","year":"2018","unstructured":"Servadio M.; Manduca A.; Melancia F.; Leboffe L.; Schiavi S.; Campolongo P.; Palmery M.; Ascenzi P.; di Masi A.; Trezza V.; Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid. Eur Neuropsychopharmacol 2018,28(1),85-96","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"e12850","DOI":"10.1111\/jne.12850","volume":"32","author":"Tsuji C.","year":"2020","unstructured":"Tsuji C.; Fujisaku T.; Tsuji T.; Oxytocin ameliorates maternal separation\u2010induced ultrasonic vocalisation calls in mouse pups prenatally exposed to valproic acid. J Neuroendocrinol 2020,32(4),e12850","journal-title":"J Neuroendocrinol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1247190","volume":"343","author":"Tyzio R.","year":"2014","unstructured":"Tyzio R.; Nardou R.; Ferrari D.C.; Tsintsadze T.; Shahrokhi A.; Eftekhari S.; Khalilov I.; Tsintsadze V.; Brouchoud C.; Chazal G.; Lemonnier E.; Lozovaya N.; Burnashev N.; Ben-Ari Y.; Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 2014,343(6171),675-679","journal-title":"Science"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2147\/NDT.S125088","volume":"13","author":"Zhang J.","year":"2017","unstructured":"Zhang J.; Liu L.M.; Ni J.F.; Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats. Neuropsychiatr Dis Treat 2017,13,835-842","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.fct.2012.10.011","volume":"51","author":"Kim P.","year":"2013","unstructured":"Kim P.; Park J.H.; Kwon K.J.; Kim K.C.; Kim H.J.; Lee J.M.; Kim H.Y.; Han S.H.; Shin C.Y.; Effects of Korean red ginseng extracts on neural tube defects and impairment of social interaction induced by prenatal exposure to valproic acid. Food Chem Toxicol 2013,51,288-296","journal-title":"Food Chem Toxicol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/jnc.12147","volume":"124","author":"Kim K.C.","year":"2013","unstructured":"Kim K.C.; Kim P.; Go H.S.; Choi C.S.; Park J.H.; Kim H.J.; Jeon S.J.; dela Pena I.C.; Han S.H.; Cheong J.H.; Ryu J.H.; Shin C.Y.; Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. J Neurochem 2013,124(6),832-843","journal-title":"J Neurochem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijdevneu.2015.04.350","volume":"44","author":"Zhao G.","year":"2015","unstructured":"Zhao G.; Gao J.; Liang S.; Wang X.; Sun C.; Xia W.; Hao Y.; Li X.; Cao Y.; Wu L.; Study of the serum levels of polyunsaturated fatty acids and the expression of related liver metabolic enzymes in a rat valproate\u2010induced autism model. Int J Dev Neurosci 2015,44(1),14-21","journal-title":"Int J Dev Neurosci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"13213","DOI":"10.1038\/s41598-017-13642-3","volume":"7","author":"Cho H.","year":"2017","unstructured":"Cho H.; Kim C.H.; Knight E.Q.; Oh H.W.; Park B.; Kim D.G.; Park H.J.; Changes in brain metabolic connectivity underlie autistic-like social deficits in a rat model of autism spectrum disorder. Sci Rep 2017,7(1),13213","journal-title":"Sci Rep"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.lfs.2017.01.012","volume":"173","author":"Wu H.","year":"2017","unstructured":"Wu H.; Wang X.; Gao J.; Liang S.; Hao Y.; Sun C.; Xia W.; Cao Y.; Wu L.; Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism. Life Sci 2017,173,43-54","journal-title":"Life Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbr.2015.02.041","volume":"286","author":"Al-Amin M.M.","year":"2015","unstructured":"Al-Amin M.M.; Rahman M.M.; Khan F.R.; Zaman F.; Mahmud Reza H.; Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism. Behav Brain Res 2015,286,112-121","journal-title":"Behav Brain Res"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neulet.2014.09.039","volume":"583","author":"Bambini-Junior V.","year":"2014","unstructured":"Bambini-Junior V.; Zanatta G.; Della F.N.G.; Mueller de Melo G.; Michels M.; Fontes-Dutra M.; Nogueira Freire V.; Riesgo R.; Gottfried C.; Resveratrol prevents social deficits in animal model of autism induced by valproic acid. Neurosci Lett 2014,583,176-181","journal-title":"Neurosci Lett"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13229-018-0221-9","volume":"9","author":"Campolongo M.","year":"2018","unstructured":"Campolongo M.; Kazlauskas N.; Falasco G.; Urrutia L.; Salgueiro N.; H\u00f6cht C.; Depino A.M.; Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment. Mol Autism 2018,9(1),36","journal-title":"Mol Autism"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbr.2016.09.003","volume":"316","author":"Chau D.K.F.","year":"2017","unstructured":"Chau D.K.F.; Choi A.Y.T.; Yang W.; Leung W.N.; Chan C.W.; Downregulation of glutamatergic and GABAergic proteins in valproric acid associated social impairment during adolescence in mice. Behav Brain Res 2017,316,255-260","journal-title":"Behav Brain Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2017.08.018","volume":"657","author":"Dai X.","year":"2017","unstructured":"Dai X.; Yin Y.; Qin L.; Valproic acid exposure decreases the mRNA stability of Bcl-2 via up-regulating miR-34a in the cerebellum of rat. Neurosci Lett 2017,657,159-165","journal-title":"Neurosci Lett"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"13077","DOI":"10.1038\/s41598-018-31385-7","volume":"8","author":"Eissa N.","year":"2018","unstructured":"Eissa N.; Jayaprakash P.; Azimullah S.; Ojha S.K.; Al-Houqani M.; Jalal F.Y.; \u0141a\u017cewska D.; Kie\u0107-Kononowicz K.; Sadek B.; The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism. Sci Rep 2018,8(1),13077","journal-title":"Sci Rep"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jnutbio.2016.07.003","volume":"35","author":"Gao J.","year":"2016","unstructured":"Gao J.; Wu H.; Cao Y.; Liang S.; Sun C.; Wang P.; Wang J.; Sun H.; Wu L.; Maternal DHA supplementation protects rat offspring against impairment of learning and memory following prenatal exposure to valproic acid. J Nutr Biochem 2016,35,87-95","journal-title":"J Nutr Biochem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"107930","DOI":"10.1016\/j.neuropharm.2019.107930","volume":"167","author":"Hirsch M.M.","year":"2020","unstructured":"Hirsch M.M.; Deckmann I.; Santos-Terra J.; Staevie G.Z.; Fontes-Dutra M.; Carello-Collar G.; K\u00f6rbes-Rockenbach M.; Brum Schwingel G.; Bauer-Negrini G.; Rabelo B.; Gon\u00e7alves M.C.B.; Corr\u00eaa-Velloso J.; Naaldijk Y.; Castillo A.R.G.; Schneider T.; Bambini-Junior V.; Ulrich H.; Gottfried C.; Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism. Neuropharmacology 2020,167,107930","journal-title":"Neuropharmacology"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fnbeh.2018.00182","volume":"12","author":"Hou Q.","year":"2018","unstructured":"Hou Q.; Wang Y.; Li Y.; Chen D.; Yang F.; Wang S.; A developmental study of abnormal behaviors and altered gabaergic signaling in the vpa-treated rat model of autism. Front Behav Neurosci 2018,12,182","journal-title":"Front Behav Neurosci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbr.2013.04.043","volume":"249","author":"Kerr D.M.","year":"2013","unstructured":"Kerr D.M.; Downey L.; Conboy M.; Finn D.P.; Roche M.; Alterations in the endocannabinoid system in the rat valproic acid model of autism. Behav Brain Res 2013,249,124-132","journal-title":"Behav Brain Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijdevneu.2018.06.009","volume":"69","author":"Khalaj R.","year":"2018","unstructured":"Khalaj R.; Hajizadeh Moghaddam A.; Zare M.; Hesperetin and it nanocrystals ameliorate social behavior deficits and oxido\u2010inflammatory stress in rat model of autism. Int J Dev Neurosci 2018,69(1),80-87","journal-title":"Int J Dev Neurosci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuropharm.2016.09.014","volume":"113","author":"Kim J.W.","year":"2017","unstructured":"Kim J.W.; Seung H.; Kim K.C.; Gonzales E.L.T.; Oh H.A.; Yang S.M.; Ko M.J.; Han S.H.; Banerjee S.; Shin C.Y.; Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism. Neuropharmacology 2017,113(Pt A),71-81","journal-title":"Neuropharmacology"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"107975","DOI":"10.1016\/j.neuropharm.2020.107975","volume":"168","author":"Matsuo K.","year":"2020","unstructured":"Matsuo K.; Yabuki Y.; Fukunaga K.; 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats. Neuropharmacology 2020,168,107975","journal-title":"Neuropharmacology"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mcn.2016.06.004","volume":"75","author":"Qin L.","year":"2016","unstructured":"Qin L.; Dai X.; Yin Y.; Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats. Mol Cell Neurosci 2016,75,27-35","journal-title":"Mol Cell Neurosci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/15569543.2019.1680563","volume":"40","author":"Rajizadeh M.A.","year":"2021","unstructured":"Rajizadeh M.A.; Afarinesh M.R.; Zarif M.; Mirasadi A.; Esmaeilpour K.; Does caffeine therapy improve cognitive impairments in valproic acid rat model of autism? Toxin Rev 2021,40(4),654-664","journal-title":"Toxin Rev"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"S269","DOI":"10.1016\/S0924-977X(16)31152-X","volume":"26","author":"Servadio M.","year":"2016","unstructured":"Servadio M.; Melancia F.; Cartocci V.; Pallottini V.; Trezza V.; Role of the endocannabinoid system in the altered social behavior observed in the rat valproic acid model of autism. Eur Neuropsychopharmacol 2016,26,S269-S270","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pbb.2015.01.021","volume":"131","author":"\u0160tef\u00e1nik P.","year":"2015","unstructured":"\u0160tef\u00e1nik P.; Olexov\u00e1 L.; Kr\u0161kov\u00e1 L.; Increased sociability and gene expression of oxytocin and its receptor in the brains of rats affected prenatally by valproic acid. Pharmacol Biochem Behav 2015,131,42-50","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.1007\/s12035-016-0074-1","volume":"54","author":"Wu H.F.","year":"2017","unstructured":"Wu H.F.; Chen P.S.; Chen Y.J.; Lee C.W.; Chen I.T.; Lin H.C.; Alleviation of N-Methyl-d-aspartate receptor-dependent long-term depression via regulation of the glycogen synthase kinase-3\u03b2 pathway in the amygdala of a valproic acid-induced animal model of autism. Mol Neurobiol 2017,54(7),5264-5276","journal-title":"Mol Neurobiol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fncel.2019.00367","volume":"13","author":"Zamberletti E.","year":"2019","unstructured":"Zamberletti E.; Gabaglio M.; Woolley-Roberts M.; Bingham S.; Rubino T.; Parolaro D.; Cannabidivarin treatment ameliorates autism-like behaviors and restores hippocampal endocannabinoid system and glia alterations induced by prenatal valproic acid exposure in rats. Front Cell Neurosci 2019,13,367","journal-title":"Front Cell Neurosci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.reprotox.2018.01.008","volume":"77","author":"Zhang R.","year":"2018","unstructured":"Zhang R.; Zhou J.; Ren J.; Sun S.; Di Y.; Wang H.; An X.; Zhang K.; Zhang J.; Qian Z.; Shi M.; Qiao Y.; Ren W.; Tian Y.; Transcriptional and splicing dysregulation in the prefrontal cortex in valproic acid rat model of autism. Reprod Toxicol 2018,77,53-61","journal-title":"Reprod Toxicol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"109644","DOI":"10.1016\/j.pnpbp.2019.109644","volume":"94","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Xiang Z.; Jia Y.; He X.; Wang L.; Cui W.; The notch signaling pathway inhibitor dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism. Prog Neuropsychopharmacol Biol Psychiatry 2019,94,109644","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fncel.2019.00479","volume":"13","author":"Schiavi S.","year":"2019","unstructured":"Schiavi S.; Iezzi D.; Manduca A.; Leone S.; Melancia F.; Carbone C.; Petrella M.; Mannaioni G.; Masi A.; Trezza V.; Reward-related behavioral, neurochemical and electrophysiological changes in a rat model of autism based on prenatal exposure to valproic acid. Front Cell Neurosci 2019,13,479","journal-title":"Front Cell Neurosci"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.brainres.2018.12.011","volume":"1708","author":"Hajisoltani R.","year":"2019","unstructured":"Hajisoltani R.; Karimi S.A.; Rahdar M.; Davoudi S.; Borjkhani M.; Hosseinmardi N.; Behzadi G.; Janahmadi M.; Hyperexcitability of hippocampal CA1 pyramidal neurons in male offspring of a rat model of autism spectrum disorder (ASD) induced by prenatal exposure to valproic acid: A possible involvement of Ih channel current. Brain Res 2019,1708,188-199","journal-title":"Brain Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12035-013-8535-2","volume":"49","author":"Kim K.C.","year":"2014","unstructured":"Kim K.C.; Lee D.K.; Go H.S.; Kim P.; Choi C.S.; Kim J.W.; Jeon S.J.; Song M.R.; Shin C.Y.; Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring. Mol Neurobiol 2014,49(1),512-528","journal-title":"Mol Neurobiol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.3390\/ijms19092840","volume":"19","author":"Wu H.F.","year":"2018","unstructured":"Wu H.F.; Chen Y.J.; Chu M.C.; Hsu Y.T.; Lu T.Y.; Chen I.T.; Chen P.; Lin H.C.; Deep brain stimulation modified autism-like deficits via the serotonin system in a valproic acid-induced rat model. Int J Mol Sci 2018,19(9),2840","journal-title":"Int J Mol Sci"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.npp.1300767","volume":"31","author":"Schneider T.","year":"2006","unstructured":"Schneider T.; Turczak J.; Przew\u0142ocki R.; Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: Issues for a therapeutic approach in autism. Neuropsychopharmacology 2006,31(1),36-46","journal-title":"Neuropsychopharmacology"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"e976123","DOI":"10.4161\/23273747.2014.976123","volume":"2","author":"Degroote S.","year":"2014","unstructured":"Degroote S.; Hunting D.; S\u00e9bire G.; Takser L.; Autistic-like traits in Lewis rats exposed perinatally to a mixture of common endocrine disruptors. Endocr Disruptors 2014,2(1),e976123","journal-title":"Endocr Disruptors"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000362645","volume":"36","author":"Ahn Y.","year":"2014","unstructured":"Ahn Y.; Narous M.; Tobias R.; Rho J.M.; Mychasiuk R.; The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder. Dev Neurosci 2014,36(5),371-380","journal-title":"Dev Neurosci"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000375489","volume":"37","author":"Codagnone M.G.","year":"2015","unstructured":"Codagnone M.G.; Podest\u00e1 M.F.; Uccelli N.A.; Rein\u00e9s A.; Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism. Dev Neurosci 2015,37(3),215-231","journal-title":"Dev Neurosci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.psychres.2017.03.003","volume":"253","author":"Du L.","year":"2017","unstructured":"Du L.; Zhao G.; Duan Z.; Li F.; Behavioral improvements in a valproic acid rat model of autism following vitamin D supplementation. Psychiatry Res 2017,253,28-32","journal-title":"Psychiatry Res"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2013.06.024","volume":"1526","author":"Edalatmanesh M.A.","year":"2013","unstructured":"Edalatmanesh M.A.; Nikfarjam H.; Vafaee F.; Moghadas M.; Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism. Brain Res 2013,1526,15-25","journal-title":"Brain Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S1461145711001714","volume":"16","author":"Kataoka S.","year":"2013","unstructured":"Kataoka S.; Takuma K.; Hara Y.; Maeda Y.; Ago Y.; Matsuda T.; Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsychopharmacol 2013,16(1),91-103","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"e55248","DOI":"10.1371\/journal.pone.0055248","volume":"8","author":"Lin H.C.","year":"2013","unstructured":"Lin H.C.; Gean P.W.; Wang C.C.; Chan Y.H.; Chen P.S.; The amygdala excitatory\/inhibitory balance in a valproate-induced rat autism model. PLoS ONE 2013,8(1),e55248","journal-title":"PLoS ONE"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.npp.1301453","volume":"33","author":"Markram K.","year":"2008","unstructured":"Markram K.; Rinaldi T.; Mendola D.L.; Sandi C.; Markram H.; Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008,33(4),901-912","journal-title":"Neuropsychopharmacology"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.pnpbp.2017.04.009","volume":"77","author":"Olde Loohuis N.F.M.","year":"2017","unstructured":"Olde Loohuis N.F.M.; Martens G.J.M.; van Bokhoven H.; Kaplan B.B.; Homberg J.R.; Aschrafi A.; Altered expression of circadian rhythm and extracellular matrix genes in the medial prefrontal cortex of a valproic acid rat model of autism. Prog Neuropsychopharmacol Biol Psychiatry 2017,77,128-132","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s11064-012-0717-1","volume":"37","author":"Sandhya T.","year":"2012","unstructured":"Sandhya T.; Sowjanya J.; Veeresh B.; Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem Res 2012,37(5),1121-1131","journal-title":"Neurochem Res"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.npp.1300518","volume":"30","author":"Schneider T.","year":"2005","unstructured":"Schneider T.; Przew\u0142ocki R.; Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology 2005,30(1),80-89","journal-title":"Neuropsychopharmacology"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1017\/S1461145713000473","volume":"16","author":"Wang C.C.","year":"2013","unstructured":"Wang C.C.; Lin H.C.; Chan Y.H.; Gean P.W.; Yang Y.K.; Chen P.S.; 5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model. Int J Neuropsychopharmacol 2013,16(9),2027-2039","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbr.2017.06.035","volume":"333","author":"Yamaguchi H.","year":"2017","unstructured":"Yamaguchi H.; Hara Y.; Ago Y.; Takano E.; Hasebe S.; Nakazawa T.; Hashimoto H.; Matsuda T.; Takuma K.; Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice. Behav Brain Res 2017,333,67-73","journal-title":"Behav Brain Res"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2013.03.030","volume":"241","author":"Bringas M.E.","year":"2013","unstructured":"Bringas M.E.; Carvajal-Flores F.N.; L\u00f3pez-Ram\u00edrez T.A.; Atzori M.; Flores G.; Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder. Neuroscience 2013,241,170-187","journal-title":"Neuroscience"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4062\/biomolther.2014.027","volume":"22","author":"Choi C.S.","year":"2014","unstructured":"Choi C.S.; Hong M.; Kim K.C.; Kim J.W.; Yang S.M.; Seung H.; Ko M.J.; Choi D.H.; You J.S.; Shin C.Y.; Bahn G.H.; Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspring. Biomol Ther 2014,22(5),406-413","journal-title":"Biomol Ther"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2016.06.035","volume":"629","author":"Olexov\u00e1 L.","year":"2016","unstructured":"Olexov\u00e1 L.; \u0160tef\u00e1nik P.; Kr\u0161kov\u00e1 L.; Increased anxiety-like behaviour and altered GABAergic system in the amygdala and cerebellum of VPA rats \u2014 An animal model of autism. Neurosci Lett 2016,629,9-14","journal-title":"Neurosci Lett"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3892\/mmr.2017.6787","volume":"16","author":"Zhang Y.","year":"2017","unstructured":"Zhang Y.; Cui W.; Zhai Q.; Zhang T.; Wen X.; N-acetylcysteine ameliorates repetitive\/stereotypic behavior due to its antioxidant properties without activation of the canonical Wnt pathway in a valproic acid-induced rat model of autism. Mol Med Rep 2017,16(2),2233-2240","journal-title":"Mol Med Rep"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1007\/s12035-017-0685-1","volume":"55","author":"Wu H.F.","year":"2018","unstructured":"Wu H.F.; Chen P.S.; Hsu Y.T.; Lee C.W.; Wang T.F.; Chen Y.J.; Lin H.C.; D-cycloserine ameliorates autism-like deficits by removing glua2-containing AMPA receptors in a valproic acid-induced rat model. Mol Neurobiol 2018,55(6),4811-4824","journal-title":"Mol Neurobiol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/ijnp\/pyy043","volume":"21","author":"Al Sagheer T.","year":"2018","unstructured":"Al Sagheer T.; Haida O.; Balbous A.; Francheteau M.; Matas E.; Fernagut P.O.; Jaber M.; Motor impairments correlate with social deficits and restricted neuronal loss in an environmental model of autism. Int J Neuropsychopharmacol 2018,21(9),871-882","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.phrs.2016.08.033","volume":"113","author":"Kerr DM","year":"2016","unstructured":"Kerr DM; Gilmartin A; Roche M; Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid. Pharmacol Res 2016,113(Pt A),228-235","journal-title":"Pharmacol Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2011.06.015","volume":"1408","author":"Bambini-Junior V.","year":"2011","unstructured":"Bambini-Junior V.; Rodrigues L.; Behr G.A.; Moreira J.C.F.; Riesgo R.; Gottfried C.; Animal model of autism induced by prenatal exposure to valproate: Behavioral changes and liver parameters. Brain Res 2011,1408,8-16","journal-title":"Brain Res"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"17443","DOI":"10.18632\/oncotarget.15245","volume":"8","author":"Gobshtis N.","year":"2017","unstructured":"Gobshtis N.; Tfilin M.; Wolfson M.; Fraifeld V.E.; Turgeman G.; Transplantation of mesenchymal stem cells reverses behavioural deficits and impaired neurogenesis caused by prenatal exposure to valproic acid. Oncotarget 2017,8(11),17443-17452","journal-title":"Oncotarget"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fnbeh.2018.00170","volume":"12","author":"Guo Q.","year":"2018","unstructured":"Guo Q.; Yin X.; Qiao M.; Jia Y.; Chen D.; Shao J.; Lebaron T.W.; Gao Y.; Shi H.; Jia B.; Hydrogen-rich water ameliorates autistic-like behavioral abnormalities in valproic acid-treated adolescent mice offspring. Front Behav Neurosci 2018,12,170","journal-title":"Front Behav Neurosci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/pcn.12833","volume":"73","author":"Huang F.","year":"2019","unstructured":"Huang F.; Chen X.; Jiang X.; Niu J.; Cui C.; Chen Z.; Sun J.; Betaine ameliorates prenatal valproic\u2010acid\u2010induced autism\u2010like behavioral abnormalities in mice by promoting homocysteine metabolism. Psychiatry Clin Neurosci 2019,73(6),317-322","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"104441","DOI":"10.1016\/j.psyneuen.2019.104441","volume":"110","author":"Kazlauskas N.","year":"2019","unstructured":"Kazlauskas N.; Seiffe A.; Campolongo M.; Zappala C.; Depino A.M.; Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: Relevance for susceptibility and resilience in autism. Psychoneuroendocrinology 2019,110,104441","journal-title":"Psychoneuroendocrinology"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainresbull.2016.03.013","volume":"124","author":"Kumar H.","year":"2016","unstructured":"Kumar H.; Sharma B.; Memantine ameliorates autistic behavior, biochemistry and blood brain barrier impairments in rats. Brain Res Bull 2016,124,27-39","journal-title":"Brain Res Bull"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainres.2015.10.052","volume":"1630","author":"Kumar H.","year":"2016","unstructured":"Kumar H.; Sharma B.; Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats. Brain Res 2016,1630,83-97","journal-title":"Brain Res"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2015.10.007","volume":"91","author":"Kumar H.","year":"2015","unstructured":"Kumar H.; Sharma B.M.; Sharma B.; Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder. Neurochem Int 2015,91,34-45","journal-title":"Neurochem Int"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13041-017-0292-0","volume":"10","author":"Lim J.S.","year":"2017","unstructured":"Lim J.S.; Lim M.Y.; Choi Y.; Ko G.; Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia. Mol Brain 2017,10(1),14","journal-title":"Mol Brain"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/aur.1338","volume":"7","author":"Lucchina L.","year":"2014","unstructured":"Lucchina L.; Depino A.M.; Altered peripheral and central inflammatory responses in a mouse model of autism. Autism Res 2014,7(2),273-289","journal-title":"Autism Res"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijdevneu.2019.05.006","volume":"76","author":"Mirza R.","year":"2019","unstructured":"Mirza R.; Sharma B.; Beneficial effects of pioglitazone, a selective peroxisome proliferator\u2010activated receptor\u2010\u03b3 agonist in prenatal valproic acid\u2010induced behavioral and biochemical autistic like features in Wistar rats. Int J Dev Neurosci 2019,76(1),6-16","journal-title":"Int J Dev Neurosci"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.brainresbull.2019.02.003","volume":"147","author":"Mirza R.","year":"2019","unstructured":"Mirza R.; Sharma B.; Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats. Brain Res Bull 2019,147,36-46","journal-title":"Brain Res Bull"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-019-05357-2","volume":"237","author":"Mohammadi S.","year":"2020","unstructured":"Mohammadi S.; Asadi-Shekaari M.; Basiri M.; Parvan M.; Shabani M.; Nozari M.; Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function. Psychopharmacology 2020,237(1),199-208","journal-title":"Psychopharmacology"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.biopha.2018.07.148","volume":"107","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Zhao S.; Liu X.; Zheng Y.; Li L.; Meng S.; Oxytocin improves animal behaviors and ameliorates oxidative stress and inflammation in autistic mice. Biomed Pharmacother 2018,107,262-269","journal-title":"Biomed Pharmacother"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11064-019-02903-4","volume":"44","author":"Wang J.","year":"2019","unstructured":"Wang J.; Feng S.; Li M.; Liu Y.; Yan J.; Tang Y.; Du D.; Chen F.; Increased expression of Kv10.2 in the hippocampus attenuates valproic acid-induced autism-like behaviors in rats. Neurochem Res 2019,44(12),2796-2808","journal-title":"Neurochem Res"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jpi.12081","volume":"56","author":"Tian Y.","year":"2014","unstructured":"Tian Y.; Yabuki Y.; Moriguchi S.; Fukunaga K.; Mao P.J.; Hong L.J.; Lu Y.M.; Wang R.; Ahmed M.M.; Liao M.H.; Huang J.Y.; Zhang R.T.; Zhou T.Y.; Long S.; Han F.; Melatonin reverses the decreases in hippocampal protein serine\/threonine kinases observed in an animal model of autism. J Pineal Res 2014,56(1),1-11","journal-title":"J Pineal Res"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.dib.2018.04.047","volume":"18","author":"Hirsch M.M.","year":"2018","unstructured":"Hirsch M.M.; Deckmann I.; Fontes-Dutra M.; Bauer-Negrini G.; Nunes G.D.F.; Nunes W.; Rabelo B.; Riesgo R.; Margis R.; Bambini-Junior V.; Gottfried C.; Data on social transmission of food preference in a model of autism induced by valproic acid and translational analysis of circulating microRNA. Data Brief 2018,18,1433-1440","journal-title":"Data Brief"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s00213-017-4703-9","volume":"234","author":"Hara Y.","year":"2017","unstructured":"Hara Y.; Ago Y.; Taruta A.; Hasebe S.; Kawase H.; Tanabe W.; Tsukada S.; Nakazawa T.; Hashimoto H.; Matsuda T.; Takuma K.; Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice. Psychopharmacology 2017,234(21),3217-3228","journal-title":"Psychopharmacology"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1002\/jnr.24072","volume":"95","author":"Cuevas-Olguin R.","year":"2017","unstructured":"Cuevas-Olguin R.; Roychowdhury S.; Banerjee A.; Garcia-Oscos F.; Esquivel-Rendon E.; Bringas M.E.; Kilgard M.P.; Flores G.; Atzori M.; Cerebrolysin prevents deficits in social behavior, repetitive conduct, and synaptic inhibition in a rat model of autism. J Neurosci Res 2017,95(12),2456-2468","journal-title":"J Neurosci Res"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.yhbeh.2017.09.013","volume":"96","author":"Hara Y.","year":"2017","unstructured":"Hara Y.; Ago Y.; Higuchi M.; Hasebe S.; Nakazawa T.; Hashimoto H.; Matsuda T.; Takuma K.; Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism. Horm Behav 2017,96,130-136","journal-title":"Horm Behav"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/aur.1596","volume":"9","author":"Hara Y.","year":"2016","unstructured":"Hara Y.; Ago Y.; Taruta A.; Katashiba K.; Hasebe S.; Takano E.; Onaka Y.; Hashimoto H.; Matsuda T.; Takuma K.; Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism. Autism Res 2016,9(9),926-939","journal-title":"Autism Res"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2018.11.003","volume":"176","author":"Kawase H.","year":"2019","unstructured":"Kawase H.; Ago Y.; Naito M.; Higuchi M.; Hara Y.; Hasebe S.; Tsukada S.; Kasai A.; Nakazawa T.; Mishina T.; Kouji H.; Takuma K.; Hashimoto H.; mS-11, a mimetic of the mSin3-binding helix in NRSF, ameliorates social interaction deficits in a prenatal valproic acid-induced autism mouse model. Pharmacol Biochem Behav 2019,176,1-5","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13041-018-0423-2","volume":"12","author":"Kotajima-Murakami H.","year":"2019","unstructured":"Kotajima-Murakami H.; Kobayashi T.; Kashii H.; Sato A.; Hagino Y.; Tanaka M.; Nishito Y.; Takamatsu Y.; Uchino S.; Ikeda K.; Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero. Mol Brain 2019,12(1),3","journal-title":"Mol Brain"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1016\/j.biopsych.2017.02.1101","volume":"81","author":"Matsuo K.","year":"2017","unstructured":"Matsuo K.; Yabuki Y.; Fukunaga K.; 493. Improvement of social interaction and cognition by oxytocin for autism-like behaviors in valproic acid-exposed rats. Biol Psychiatry 2017,81(10),S200-S201","journal-title":"Biol Psychiatry"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2015.05.006","volume":"80","author":"Olde Loohuis N.F.M.","year":"2015","unstructured":"Olde Loohuis N.F.M.; Kole K.; Glennon J.C.; Karel P.; Van der Borg G.; Van Gemert Y.; Van den Bosch D.; Meinhardt J.; Kos A.; Shahabipour F.; Tiesinga P.; van Bokhoven H.; Martens G.J.M.; Kaplan B.B.; Homberg J.R.; Aschrafi A.; Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism. Neurobiol Dis 2015,80,42-53","journal-title":"Neurobiol Dis"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3389\/fneur.2018.01052","volume":"9","author":"Wang X.","year":"2018","unstructured":"Wang X.; Tao J.; Qiao Y.; Luo S.; Zhao Z.; Gao Y.; Guo J.; Kong J.; Chen C.; Ge L.; Zhang B.; Guo P.; Liu L.; Song Y.; Gastrodin rescues autistic-like phenotypes in valproic acid-induced animal model. Front Neurol 2018,9,1052","journal-title":"Front Neurol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3892\/ijmm.2014.1996","volume":"35","author":"Zhang Y.","year":"2015","unstructured":"Zhang Y.; Yang C.; Yuan G.; Wang Z.; Cui W.; Li R.; Sulindac attenuates valproic acid-induced oxidative stress levels in primary cultured cortical neurons and ameliorates repetitive\/stereotypic-like movement disorders in Wistar rats prenatally exposed to valproic acid. Int J Mol Med 2015,35(1),263-270","journal-title":"Int J Mol Med"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"108775","DOI":"10.1016\/j.cbi.2019.108775","volume":"312","author":"Eissa N.","year":"2019","unstructured":"Eissa N.; Azimullah S.; Jayaprakash P.; Jayaraj R.L.; Reiner D.; Ojha S.K.; Beiram R.; Stark H.; \u0141a\u017cewska D.; Kie\u0107-Kononowicz K.; Sadek B.; The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice. Chem Biol Interact 2019,312,108775","journal-title":"Chem Biol Interact"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbr.2015.04.022","volume":"289","author":"Hara Y.","year":"2015","unstructured":"Hara Y.; Takuma K.; Takano E.; Katashiba K.; Taruta A.; Higashino K.; Hashimoto H.; Ago Y.; Matsuda T.; Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model. Behav Brain Res 2015,289,39-47","journal-title":"Behav Brain Res"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s11064-012-0724-2","volume":"37","author":"Zhang Y.","year":"2012","unstructured":"Zhang Y.; Sun Y.; Wang F.; Wang Z.; Peng Y.; Li R.; Downregulating the canonical Wnt\/\u03b2-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress. Neurochem Res 2012,37(7),1409-1419","journal-title":"Neurochem Res"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/aur.1852","volume":"10","author":"Anshu K.","year":"2017","unstructured":"Anshu K.; Nair A.K.; Kumaresan U.D.; Kutty B.M.; Srinath S.; Laxmi T.R.; Altered attentional processing in male and female rats in a prenatal valproic acid exposure model of autism spectrum disorder. Autism Res 2017,10(12),1929-1944","journal-title":"Autism Res"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fnins.2015.00127","volume":"9","author":"Favre M.","year":"2015","unstructured":"Favre M.; \u00c3\u00b4 R.; La Mendola D.; Meystre J.; Christodoulou D.; Cochrane M.J.; Markram H.; Markram K.; Predictable enriched environment prevents development of hyper-emotionality in the VPA rat model of autism. Front Neurosci 2015,9(MAR),127","journal-title":"Front Neurosci"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.neuropharm.2012.05.042","volume":"63","author":"Foley A.G.","year":"2012","unstructured":"Foley A.G.; Gannon S.; Rombach-Mullan N.; Prendergast A.; Barry C.; Cassidy A.W.; Regan C.M.; Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder. Neuropharmacology 2012,63(4),750-760","journal-title":"Neuropharmacology"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejphar.2014.01.050","volume":"727","author":"Foley A.G.","year":"2014","unstructured":"Foley A.G.; Cassidy A.W.; Regan C.M.; Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders. Eur J Pharmacol 2014,727(1),80-86","journal-title":"Eur J Pharmacol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2131\/jts.43.631","volume":"43","author":"Win-Shwe T.T.","year":"2018","unstructured":"Win-Shwe T.T.; Nway N.C.; Imai M.; Lwin T.T.; Mar O.; Watanabe H.; Social behavior, neuroimmune markers and glutamic acid decarboxylase levels in a rat model of valproic acid-induced autism. J Toxicol Sci 2018,43(11),631-643","journal-title":"J Toxicol Sci"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","volume":"33","author":"Schneider T.","year":"2008","unstructured":"Schneider T.; Roman A.; Basta-Kaim A.; Kubera M.; Budziszewska B.; Schneider K.; Przew\u0142ocki R.; Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 2008,33(6),728-740","journal-title":"Psychoneuroendocrinology"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fnbeh.2014.00387","volume":"8","author":"Banerjee A.","year":"2014","unstructured":"Banerjee A.; Engineer C.T.; Sauls B.L.; Morales A.A.; Kilgard M.P.; Ploski J.E.; Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero. Front Behav Neurosci 2014,8(387),387","journal-title":"Front Behav Neurosci"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.5958\/0974-360X.2017.00260.8","volume":"10","author":"Kumaravel P.","year":"2017","unstructured":"Kumaravel P.; Melchias G.; Vasanth N.; Manivasagam T.; Epigallocatechin gallate attenuates behavioral defects in sodium valproate induced autism rat model. Res J Pharm Technol 2017,10(5),1477","journal-title":"Res J Pharm Technol"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fncel.2019.00111","volume":"13","author":"Song T.J.","year":"2019","unstructured":"Song T.J.; Lan X.Y.; Wei M.P.; Zhai F.J.; Boeckers T.M.; Wang J.N.; Yuan S.; Jin M.Y.; Xie Y.F.; Dang W.W.; Zhang C.; Sch\u00f6n M.; Song P.W.; Qiu M.H.; Song Y.Y.; Han S.P.; Han J.S.; Zhang R.; Altered behaviors and impaired synaptic function in a novel rat model with a complete shank3 deletion. Front Cell Neurosci 2019,13,111","journal-title":"Front Cell Neurosci"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1038\/s41467-021-25487-6","volume":"12","author":"Watanabe S.","year":"2021","unstructured":"Watanabe S.; Kurotani T.; Oga T.; Noguchi J.; Isoda R.; Nakagami A.; Sakai K.; Nakagaki K.; Sumida K.; Hoshino K.; Saito K.; Miyawaki I.; Sekiguchi M.; Wada K.; Minamimoto T.; Ichinohe N.; Functional and molecular characterization of a non-human primate model of autism spectrum disorder shows similarity with the human disease. Nat Commun 2021,12(1),5388","journal-title":"Nat Commun"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41398-019-0608-1","volume":"9","author":"Zhao H.","year":"2019","unstructured":"Zhao H.; Wang Q.; Yan T.; Zhang Y.; Xu H.; Yu H.; Tu Z.; Guo X.; Jiang Y.; Li X.; Zhou H.; Zhang Y.Q.; Maternal valproic acid exposure leads to neurogenesis defects and autism-like behaviors in non-human primates. Transl Psychiatry 2019,9(1),267","journal-title":"Transl Psychiatry"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bbr.2015.06.006","volume":"292","author":"Yasue M.","year":"2015","unstructured":"Yasue M.; Nakagami A.; Banno T.; Nakagaki K.; Ichinohe N.; Kawai N.; Indifference of marmosets with prenatal valproate exposure to third-party non-reciprocal interactions with otherwise avoided non-reciprocal individuals. Behav Brain Res 2015,292,323-326","journal-title":"Behav Brain Res"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1038\/s41598-018-24202-8","volume":"8","author":"Sgad\u00f2 P.","year":"2018","unstructured":"Sgad\u00f2 P.; Rosa-Salva O.; Versace E.; Vallortigara G.; Embryonic exposure to valproic acid impairs social predispositions of newly-hatched chicks. Sci Rep 2018,8(1),5919","journal-title":"Sci Rep"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fphys.2019.00501","volume":"10","author":"Lorenzi E.","year":"2019","unstructured":"Lorenzi E.; Pross A.; Rosa-Salva O.; Versace E.; Sgad\u00f2 P.; Vallortigara G.; Embryonic exposure to valproic acid affects social predispositions for dynamic cues of animate motion in newly-hatched chicks. Front Physiol 2019,10,501","journal-title":"Front Physiol"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"733140","DOI":"10.3389\/fnbeh.2021.733140","volume":"15","author":"Adiletta A.","year":"2021","unstructured":"Adiletta A.; Pedrana S.; Rosa-Salva O.; Sgad\u00f2 P.; Spontaneous visual preference for face-like stimuli is impaired in newly-hatched domestic chicks exposed to valproic acid during embryogenesis. Front Behav Neurosci 2021,15,733140","journal-title":"Front Behav Neurosci"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"tgac041","DOI":"10.1093\/texcom\/tgac041","author":"Matsushima T.","year":"2022","unstructured":"Matsushima T.; Miura M.; Patzke N.; Toji N.; Wada K.; Ogura Y.; Fetal blockade of nicotinic acetylcholine transmission causes autism-like impairment of biological motion preference in the neonatal chick. Cereb Cortex 2022,tgac041","journal-title":"Cereb Cortex"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00213-013-2979-y","volume":"227","author":"Nishigori H.","year":"2013","unstructured":"Nishigori H.; Kagami K.; Takahashi A.; Tezuka Y.; Sanbe A.; Nishigori H.; Impaired social behavior in chicks exposed to sodium valproate during the last week of embryogenesis. Psychopharmacology 2013,227(3),393-402","journal-title":"Psychopharmacology"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3389\/fphys.2019.00881","volume":"10","author":"Zachar G.","year":"2019","unstructured":"Zachar G.; T\u00f3th A.S.; Gerecsei L.I.; Zseb\u0151k S.; \u00c1d\u00e1m \u00c1.; Csillag A.; Valproate exposure in ovo attenuates the acquisition of social preferences of young post-hatch domestic chicks. Front Physiol 2019,10,881","journal-title":"Front Physiol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ntt.2018.01.002","volume":"66","author":"Chen J.","year":"2018","unstructured":"Chen J.; Lei L.; Tian L.; Hou F.; Roper C.; Ge X.; Zhao Y.; Chen Y.; Dong Q.; Tanguay R.L.; Huang C.; Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): An aquatic model for autism. Neurotoxicol Teratol 2018,66,8-16","journal-title":"Neurotoxicol Teratol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.vascn.2018.11.006","volume":"95","author":"Dwivedi S.","year":"2019","unstructured":"Dwivedi S.; Medishetti R.; Rani R.; Sevilimedu A.; Kulkarni P.; Yogeeswari P.; Larval zebrafish model for studying the effects of valproic acid on neurodevelopment: An approach towards modeling autism. J Pharmacol Toxicol Methods 2019,95,56-65","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ntt.2015.10.002","volume":"52","author":"Zimmermann F.F.","year":"2015","unstructured":"Zimmermann F.F.; Gaspary K.V.; Leite C.E.; De Paula C.G.; Bonan C.D.; Embryological exposure to valproic acid induces social interaction deficits in zebrafish (Danio rerio): A developmental behavior analysis. Neurotoxicol Teratol 2015,52(Pt A),36-41","journal-title":"Neurotoxicol Teratol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/bph.14124","volume":"175","author":"Baronio D.","year":"2018","unstructured":"Baronio D.; Puttonen H.A.J.; Sundvik M.; Semenova S.; Lehtonen E.; Panula P.; Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio). Br J Pharmacol 2018,175(5),797-809","journal-title":"Br J Pharmacol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1210\/en.2018-00220","volume":"159","author":"Bell M.R.","year":"2018","unstructured":"Bell M.R.; Comparing postnatal development of gonadal hormones and associated social behaviors in rats, mice, and humans. Endocrinology 2018,159(7),2596-2613","journal-title":"Endocrinology"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/B978-0-12-800511-8.00002-2","author":"Carter M.","year":"2015","unstructured":"Carter M.; Animal behavior. Guide to Research Techniques in Neuroscience 2015,39-71","journal-title":"Guide to Research Techniques in Neuroscience"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nicl.2012.11.006","volume":"2","author":"Rudie J.D.","year":"2013","unstructured":"Rudie J.D.; Brown J.A.; Beck-Pancer D.; Hernandez L.M.; Dennis E.L.; Thompson P.M.; Bookheimer S.Y.; Dapretto M.; Altered functional and structural brain network organization in autism. Neuroimage Clin 2013,2,79-94","journal-title":"Neuroimage Clin"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.nicl.2016.06.004","volume":"12","author":"Zhao Y.","year":"2016","unstructured":"Zhao Y.; Chen H.; Li Y.; Lv J.; Jiang X.; Ge F.; Zhang T.; Zhang S.; Ge B.; Lyu C.; Zhao S.; Han J.; Guo L.; Liu T.; Connectome-scale group-wise consistent resting-state network analysis in autism spectrum disorder. Neuroimage Clin 2016,12,23-33","journal-title":"Neuroimage Clin"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/hbm.24812","volume":"41","author":"Guo X.","year":"2020","unstructured":"Guo X.; Duan X.; Chen H.; He C.; Xiao J.; Han S.; Fan Y.S.; Guo J.; Chen H.; Altered inter\u2010 and intrahemispheric functional connectivity dynamics in autistic children. Hum Brain Mapp 2020,41(2),419-428","journal-title":"Hum Brain Mapp"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/15622975.2015.1085597","volume":"17","author":"Uzunova G.","year":"2016","unstructured":"Uzunova G.; Pallanti S.; Hollander E.; Excitatory\/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics. World J Biol Psychiatry 2016,17(3),174-186","journal-title":"World J Biol Psychiatry"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fnins.2015.00420","volume":"9","author":"Hampson D.R.","year":"2015","unstructured":"Hampson D.R.; Blatt G.J.; Autism spectrum disorders and neuropathology of the cerebellum. Front Neurosci 2015,9,420","journal-title":"Front Neurosci"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.nicl.2015.02.007","volume":"7","author":"D\u2019Mello A.M.","year":"2015","unstructured":"D\u2019Mello A.M.; Crocetti D.; Mostofsky S.H.; Stoodley C.J.; Cerebellar gray matter and lobular volumes correlate with core autism symptoms. Neuroimage Clin 2015,7,631-639","journal-title":"Neuroimage Clin"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s12311-013-0475-x","volume":"12","author":"Hanaie R.","year":"2013","unstructured":"Hanaie R.; Mohri I.; Kagitani-Shimono K.; Tachibana M.; Azuma J.; Matsuzaki J.; Watanabe Y.; Fujita N.; Taniike M.; Altered microstructural connectivity of the superior cerebellar peduncle is related to motor dysfunction in children with autistic spectrum disorders. Cerebellum 2013,12(5),645-656","journal-title":"Cerebellum"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijdevneu.2004.09.006","volume":"23","author":"Bauman M.L.","year":"2005","unstructured":"Bauman M.L.; Kemper T.L.; Neuroanatomic observations of the brain in autism: A review and future directions. Int J Dev Neurosci 2005,23(2-3),183-187","journal-title":"Int J Dev Neurosci"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4103\/1673-5374.202926","volume":"12","author":"Pang Y.","year":"2017","unstructured":"Pang Y.; Fan L-W.; Dysregulation of neurogenesis by neuroinflammation: key differences in neurodevelopmental and neurological disorders. Neural Regen Res 2017,12(3),366-371","journal-title":"Neural Regen Res"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fnins.2015.00313","volume":"9","author":"Subramanian M.","year":"2015","unstructured":"Subramanian M.; Timmerman C.K.; Schwartz J.L.; Pham D.L.; Meffert M.K.; Characterizing autism spectrum disorders by key biochemical pathways. Front Neurosci 2015,9,313","journal-title":"Front Neurosci"},{"key":"ref=209","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/bs.pmbts.2020.04.014","author":"Chen O.","year":"2020","unstructured":"Chen O.; Tahmazian I.; Ferrara H.J.; Hu B.; Chomiak T.; The early overgrowth theory of autism spectrum disorder: Insight into convergent mechanisms from valproic acid exposure and translational models. Progress in Molecular Biology and Translational Science 2020,275-300","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cortex.2015.02.008","volume":"66","author":"Libero L.E.","year":"2015","unstructured":"Libero L.E.; DeRamus T.P.; Lahti A.C.; Deshpande G.; Kana R.K.; Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates. Cortex 2015,66,46-59","journal-title":"Cortex"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1177\/0883073807304005","volume":"22","author":"Mraz K.D.","year":"2007","unstructured":"Mraz K.D.; Green J.; Dumont-Mathieu T.; Makin S.; Fein D.; Correlates of head circumference growth in infants later diagnosed with autism spectrum disorders. J Child Neurol 2007,22(6),700-713","journal-title":"J Child Neurol"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00004583-199702000-00019","volume":"36","author":"Lainhart J.","year":"1997","unstructured":"Lainhart J.; Piven J.; Wzorek M.; Landa R.; Santangelo S.L.; Coon H.; Folstein S.; Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997,36(2),282-290","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pscychresns.2015.08.016","volume":"234","author":"Sacco R.","year":"2015","unstructured":"Sacco R.; Gabriele S.; Persico A.M.; Head circumference and brain size in autism spectrum disorder: A systematic review and meta-analysis. Psychiatry Res Neuroimaging 2015,234(2),239-251","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbi.2013.01.084","volume":"30","author":"Nordahl C.W.","year":"2013","unstructured":"Nordahl C.W.; Braunschweig D.; Iosif A.M.; Lee A.; Rogers S.; Ashwood P.; Amaral D.G.; Van de Water J.; Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav Immun 2013,30,61-65","journal-title":"Brain Behav Immun"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/EDE.0b013e31829e1d45","volume":"24","author":"Sur\u00e9n P.","year":"2013","unstructured":"Sur\u00e9n P.; Stoltenberg C.; Bresnahan M.; Hirtz D.; Lie K.K.; Lipkin W.I.; Magnus P.; Reichborn-Kjennerud T.; Schj\u00f8lberg S.; Susser E.; \u00d8yen A.S.; Li L.; Hornig M.; Early growth patterns in children with autism. Epidemiology 2013,24(5),660-670","journal-title":"Epidemiology"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/ajmg.a.31465","volume":"140A","author":"Lainhart J.E.","year":"2006","unstructured":"Lainhart J.E.; Bigler E.D.; Bocian M.; Coon H.; Dinh E.; Dawson G.; Deutsch C.K.; Dunn M.; Estes A.; Tager-Flusberg H.; Folstein S.; Hepburn S.; Hyman S.; McMahon W.; Minshew N.; Munson J.; Osann K.; Ozonoff S.; Rodier P.; Rogers S.; Sigman M.; Spence M.A.; Stodgell C.J.; Volkmar F.; Head circumference and height in autism: A study by the collaborative program of excellence in autism. Am J Med Genet A 2006,140A(21),2257-2274","journal-title":"Am J Med Genet A"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1001\/jama.2011.1638","volume":"306","author":"Courchesne E.","year":"2011","unstructured":"Courchesne E.; Mouton P.R.; Calhoun M.E.; Semendeferi K.; Ahrens-Barbeau C.; Hallet M.J.; Barnes C.C.; Pierce K.; Neuron number and size in prefrontal cortex of children with autism. JAMA 2011,306(18),2001-2010","journal-title":"JAMA"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/mp.2016.95","volume":"22","author":"Marchetto M.C.","year":"2017","unstructured":"Marchetto M.C.; Belinson H.; Tian Y.; Freitas B.C.; Fu C.; Vadodaria K.C.; Beltrao-Braga P.C.; Trujillo C.A.; Mendes A.P.D.; Padmanabhan K.; Nunez Y.; Ou J.; Ghosh H.; Wright R.; Brennand K.J.; Pierce K.; Eichenfield L.; Pramparo T.; Eyler L.T.; Barnes C.C.; Courchesne E.; Geschwind D.H.; Gage F.H.; Wynshaw-Boris A.; Muotri A.R.; Altered proliferation and networks in neural cells derived from idiopathic autistic individuals. Mol Psychiatry 2017,22(6),820-835","journal-title":"Mol Psychiatry"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.biopsych.2006.01.015","volume":"61","author":"Hutsler J.J.","year":"2007","unstructured":"Hutsler J.J.; Love T.; Zhang H.; Histological and magnetic resonance imaging assessment of cortical layering and thickness in autism spectrum disorders. Biol Psychiatry 2007,61(4),449-457","journal-title":"Biol Psychiatry"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-010-0655-4","volume":"119","author":"Wegiel J.","year":"2010","unstructured":"Wegiel J.; Kuchna I.; Nowicki K.; Imaki H.; Wegiel J.; Marchi E.; Ma S.Y.; Chauhan A.; Chauhan V.; Bobrowicz T.W.; de Leon M.; Louis L.A.S.; Cohen I.L.; London E.; Brown W.T.; Wisniewski T.; The neuropathology of autism: Defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol 2010,119(6),755-770","journal-title":"Acta Neuropathol"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"16659","DOI":"10.1073\/pnas.0407643101","volume":"101","author":"Hsieh J.","year":"2004","unstructured":"Hsieh J.; Nakashima K.; Kuwabara T.; Mejia E.; Gage F.H.; Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci 2004,101(47),16659-16664","journal-title":"Proc Natl Acad Sci"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.neuropharm.2012.07.028","volume":"63","author":"Go H.S.","year":"2012","unstructured":"Go H.S.; Kim K.C.; Choi C.S.; Jeon S.J.; Kwon K.J.; Han S.H.; Lee J.; Cheong J.H.; Ryu J.H.; Kim C.H.; Ko K.H.; Shin C.Y.; Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3\u03b2\/\u03b2-catenin pathway. Neuropharmacology 2012,63(6),1028-1041","journal-title":"Neuropharmacology"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/jnc.15501","volume":"159","author":"Bicker F.","year":"2021","unstructured":"Bicker F.; Nardi L.; Maier J.; Vasic V.; Schmeisser M.J.; Criss\u2010crossing autism spectrum disorder and adult neurogenesis. J Neurochem 2021,159(3),452-478","journal-title":"J Neurochem"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fncel.2017.00359","volume":"11","author":"Gilbert J.","year":"2017","unstructured":"Gilbert J.; Man H.Y.; Fundamental elements in autism: From neurogenesis and neurite growth to synaptic plasticity. Front Cell Neurosci 2017,11,359","journal-title":"Front Cell Neurosci"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12640-016-9660-2","volume":"31","author":"Watanabe Y.","year":"2017","unstructured":"Watanabe Y.; Murakami T.; Kawashima M.; Hasegawa-Baba Y.; Mizukami S.; Imatanaka N.; Akahori Y.; Yoshida T.; Shibutani M.; Maternal exposure to valproic acid primarily targets interneurons followed by late effects on neurogenesis in the hippocampal dentate gyrus in rat offspring. Neurotox Res 2017,31(1),46-62","journal-title":"Neurotox Res"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0892-0362(99)00083-5","volume":"22","author":"Ingram J.L.","year":"2000","unstructured":"Ingram J.L.; Peckham S.M.; Tisdale B.; Rodier P.M.; Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 2000,22(3),319-324","journal-title":"Neurotoxicol Teratol"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijdevneu.2014.10.003","volume":"40","author":"Mowery T.M.","year":"2015","unstructured":"Mowery T.M.; Wilson S.M.; Kostylev P.V.; Dina B.; Buchholz J.B.; Prieto A.L.; Garraghty P.E.; Embryological exposure to valproic acid disrupts morphology of the deep cerebellar nuclei in a sexually dimorphic way. Int J Dev Neurosci 2015,40(1),15-23","journal-title":"Int J Dev Neurosci"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fncel.2018.00500","volume":"12","author":"Wang R.","year":"2018","unstructured":"Wang R.; Tan J.; Guo J.; Zheng Y.; Han Q.; So K.F.; Yu J.; Zhang L.; Aberrant development and synaptic transmission of cerebellar cortex in a VPA induced mouse autism model. Front Cell Neurosci 2018,12,500","journal-title":"Front Cell Neurosci"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11689-009-9023-x","volume":"1","author":"Gogolla N.","year":"2009","unstructured":"Gogolla N.; LeBlanc J.J.; Quast K.B.; S\u00fcdhof T.C.; Fagiolini M.; Hensch T.K.; Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 2009,1(2),172-181","journal-title":"J Neurodev Disord"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1254\/jphs.12025SC","volume":"118","author":"Hara Y.","year":"2012","unstructured":"Hara Y.; Maeda Y.; Kataoka S.; Ago Y.; Takuma K.; Matsuda T.; Effect of prenatal valproic acid exposure on cortical morphology in female mice. J Pharmacol Sci 2012,118(4),543-546","journal-title":"J Pharmacol Sci"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"10908","DOI":"10.1523\/JNEUROSCI.0229-16.2016","volume":"36","author":"Fujimura K.","year":"2016","unstructured":"Fujimura K.; Mitsuhashi T.; Shibata S.; Shimozato S.; Takahashi T.; In utero exposure to valproic acid induces neocortical dysgenesis via dysregulation of neural progenitor cell proliferation\/differentiation. J Neurosci 2016,36(42),10908-10919","journal-title":"J Neurosci"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"bio059567","DOI":"10.1242\/bio.059567","volume":"12","author":"Dixon S.C.","year":"2023","unstructured":"Dixon S.C.; Calder B.J.; Lilya S.M.; Davies B.M.; Martin A.; Peterson M.; Hansen J.M.; Suli A.; Valproic acid affects neurogenesis during early optic tectum development in zebrafish. Biol Open 2023,12(1),bio059567","journal-title":"Biol Open"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/dvdy.24173","volume":"243","author":"Dozawa M.","year":"2014","unstructured":"Dozawa M.; Kono H.; Sato Y.; Ito Y.; Tanaka H.; Ohshima T.; Valproic acid, a histone deacetylase inhibitor, regulates cell proliferation in the adult zebrafish optic tectum. Dev Dyn 2014,243(11),1401-1415","journal-title":"Dev Dyn"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"1151162","DOI":"10.3389\/fnmol.2023.1151162","volume":"16","author":"Chen A.","year":"2023","unstructured":"Chen A.; Wang M.; Xu C.; Zhao Y.; Xian P.; Li Y.; Zheng W.; Yi X.; Wu S.; Wang Y.; Glycolysis mediates neuron specific histone acetylation in valproic acid-induced human excitatory neuron differentiation. Front Mol Neurosci 2023,16,1151162","journal-title":"Front Mol Neurosci"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fnsyn.2018.00015","volume":"10","author":"Wang H.","year":"2018","unstructured":"Wang H.; Modeling neurological diseases with human brain organoids. Front Synaptic Neurosci 2018,10,15","journal-title":"Front Synaptic Neurosci"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.molmed.2018.09.005","volume":"24","author":"Trujillo C.A.","year":"2018","unstructured":"Trujillo C.A.; Muotri A.R.; Brain Organoids and the Study of Neurodevelopment. Trends Mol Med 2018,24(12),982-990","journal-title":"Trends Mol Med"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"574382","DOI":"10.3389\/fcell.2020.574382","volume":"8","author":"Hansen A.H.","year":"2020","unstructured":"Hansen A.H.; Hippenmeyer S.; Non-cell-autonomous mechanisms in radial projection neuron migration in the developing cerebral cortex. Front Cell Dev Biol 2020,8,574382","journal-title":"Front Cell Dev Biol"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1242\/dev.087668","volume":"140","author":"Gao P.","year":"2013","unstructured":"Gao P.; Sultan K.T.; Zhang X.J.; Shi S.H.; Lineage-dependent circuit assembly in the neocortex. Development 2013,140(13),2645-2655","journal-title":"Development"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa1307491","volume":"370","author":"Stoner R.","year":"2014","unstructured":"Stoner R.; Chow M.L.; Boyle M.P.; Sunkin S.M.; Mouton P.R.; Roy S.; Wynshaw-Boris A.; Colamarino S.A.; Lein E.S.; Courchesne E.; Patches of disorganization in the neocortex of children with autism. N Engl J Med 2014,370(13),1209-1219","journal-title":"N Engl J Med"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/brain\/121.5.889","volume":"121","author":"Bailey A.","year":"1998","unstructured":"Bailey A.; Luthert P.; Dean A.; Harding B.; Janota I.; Montgomery M.; Rutter M.; Lantos P.; A clinicopathological study of autism. Brain 1998,121(5),889-905","journal-title":"Brain"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00005072-199807000-00001","volume":"57","author":"Kemper T.L.","year":"1998","unstructured":"Kemper T.L.; Bauman M.; Neuropathology of infantile autism. J Neuropathol Exp Neurol 1998,57(7),645-652","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00401-009-0568-2","volume":"118","author":"Simms M.L.","year":"2009","unstructured":"Simms M.L.; Kemper T.L.; Timbie C.M.; Bauman M.L.; Blatt G.J.; The anterior cingulate cortex in autism: heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups. Acta Neuropathol 2009,118(5),673-684","journal-title":"Acta Neuropathol"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0166-2236(98)01313-7","volume":"21","author":"Goldowitz D.","year":"1998","unstructured":"Goldowitz D.; Hamre K.; The cells and molecules that make a cerebellum. Trends Neurosci 1998,21(9),375-382","journal-title":"Trends Neurosci"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1073\/pnas.1716479115","volume":"115","author":"Sakai A.","year":"2018","unstructured":"Sakai A.; Matsuda T.; Doi H.; Nagaishi Y.; Kato K.; Nakashima K.; Ectopic neurogenesis induced by prenatal antiepileptic drug exposure augments seizure susceptibility in adult mice. Proc Natl Acad Sci 2018,115(16),4270-4275","journal-title":"Proc Natl Acad Sci"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1159\/000345353","volume":"34","author":"Choe Y.","year":"2012","unstructured":"Choe Y.; Pleasure S.J.; Wnt signaling regulates intermediate precursor production in the postnatal dentate gyrus by regulating CXCR4 expression. Dev Neurosci 2012,34(6),502-514","journal-title":"Dev Neurosci"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/hipo.22180","volume":"23","author":"Schulthei\u00df C.","year":"2013","unstructured":"Schulthei\u00df C.; Abe P.; Hoffmann F.; Mueller W.; Kreuder A.E.; Sch\u00fctz D.; Haege S.; Redecker C.; Keiner S.; Kannan S.; Claasen J.H.; Pfrieger F.W.; Stumm R.; CXCR4 prevents dispersion of granule neuron precursors in the adult dentate gyrus. Hippocampus 2013,23(12),1345-1358","journal-title":"Hippocampus"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1038\/npp.2010.97","volume":"35","author":"Tsai L.K.","year":"2010","unstructured":"Tsai L.K.; Leng Y.; Wang Z.; Leeds P.; Chuang D.M.; The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms. Neuropsychopharmacology 2010,35(11),2225-2237","journal-title":"Neuropsychopharmacology"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.molmed.2012.01.003","volume":"18","author":"Pe\u00f1agarikano O.","year":"2012","unstructured":"Pe\u00f1agarikano O.; Geschwind D.H.; What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med 2012,18(3),156-163","journal-title":"Trends Mol Med"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"a001644","DOI":"10.1101\/cshperspect.a001644","volume":"1","author":"Tahirovic S.","year":"2009","unstructured":"Tahirovic S.; Bradke F.; Neuronal polarity. Cold Spring Harb Perspect Biol 2009,1(3),a001644-a001644","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/nrn1769","volume":"6","author":"Migliore M.","year":"2005","unstructured":"Migliore M.; Shepherd G.M.; An integrated approach to classifying neuronal phenotypes. Nat Rev Neurosci 2005,6(10),810-818","journal-title":"Nat Rev Neurosci"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"247","DOI":"10.31887\/DCNS.2013.15.3\/osporns","volume":"15","author":"Sporns O.","year":"2013","unstructured":"Sporns O.; Structure and function of complex brain networks. Dialogues Clin Neurosci 2013,15(3),247-262","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/ar.21243","volume":"294","author":"Azmitia E.C.","year":"2011","unstructured":"Azmitia E.C.; Singh J.S.; Hou X.P.; Wegiel J.; Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec 2011,294(10),1653-1662","journal-title":"Anat Rec"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuropharm.2011.02.002","volume":"60","author":"Azmitia E.C.","year":"2011","unstructured":"Azmitia E.C.; Singh J.S.; Whitaker-Azmitia P.M.; Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology 2011,60(7-8),1347-1354","journal-title":"Neuropharmacology"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1212\/WNL.58.3.428","volume":"58","author":"Casanova M.F.","year":"2002","unstructured":"Casanova M.F.; Buxhoeveden D.P.; Switala A.E.; Roy E.; Minicolumnar pathology in autism. Neurology 2002,58(3),428-432","journal-title":"Neurology"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s004010050401","volume":"91","author":"Raymond G.V.","year":"1995","unstructured":"Raymond G.V.; Bauman M.L.; Kemper T.L.; Hippocampus in autism: A Golgi analysis. Acta Neuropathol 1995,91(1),117-119","journal-title":"Acta Neuropathol"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2990.2004.00574.x","volume":"30","author":"Mukaetova-Ladinska E.B.","year":"2004","unstructured":"Mukaetova-Ladinska E.B.; Arnold H.; Jaros E.; Perry R.; Perry E.; Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals. Neuropathol Appl Neurobiol 2004,30(6),615-623","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainres.2009.09.120","volume":"1309","author":"Hutsler J.J.","year":"2010","unstructured":"Hutsler J.J.; Zhang H.; Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res 2010,1309,83-94","journal-title":"Brain Res"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/cercor\/bhu291","volume":"26","author":"Mart\u00ednez-Cerde\u00f1o V.","year":"2016","unstructured":"Mart\u00ednez-Cerde\u00f1o V.; Camacho J.; Fox E.; Miller E.; Ariza J.; Kienzle D.; Plank K.; Noctor S.C.; Van de Water J.; Prenatal exposure to autism-specific maternal autoantibodies alters proliferation of cortical neural precursor cells, enlarges brain, and increases neuronal size in adult animals. Cereb Cortex 2016,26(1),374-383","journal-title":"Cereb Cortex"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/dev.20337","volume":"50","author":"Snow W.M.","year":"2008","unstructured":"Snow W.M.; Hartle K.; Ivanco T.L.; Altered morphology of motor cortex neurons in the VPA rat model of autism. Dev Psychobiol 2008,50(7),633-639","journal-title":"Dev Psychobiol"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000341786","volume":"34","author":"Mychasiuk R.","year":"2012","unstructured":"Mychasiuk R.; Richards S.; Nakahashi A.; Kolb B.; Gibb R.; Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy. Dev Neurosci 2012,34(2-3),268-276","journal-title":"Dev Neurosci"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/epi.16915","volume":"62","author":"Muhsen M.","year":"2021","unstructured":"Muhsen M.; Youngs J.; Riu A.; Gustafsson J.\u00c5.; Kondamadugu V.S.; Garyfalidis E.; Bondesson M.; Folic acid supplementation rescues valproic acid\u2010induced developmental neurotoxicity and behavioral alterations in zebrafish embryos. Epilepsia 2021,62(7),1689-1700","journal-title":"Epilepsia"},{"key":"ref=262","first-page":"107","volume":"7","author":"Jacob J.","year":"2013","unstructured":"Jacob J.; Ribes V.; Moore S.; Constable SC.; Sasai N.; Gerety SS.; Valproic acid silencing of ascl1b\/ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome. Dis Model Mech 2013,7(1),107-117","journal-title":"Dis Model Mech"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1007\/s11064-016-1969-y","volume":"41","author":"Kawanai T.","year":"2016","unstructured":"Kawanai T.; Ago Y.; Watanabe R.; Inoue A.; Taruta A.; Onaka Y.; Hasebe S.; Hashimoto H.; Matsuda T.; Takuma K.; Prenatal exposure to histone deacetylase inhibitors affects gene expression of autism-related molecules and delays neuronal maturation. Neurochem Res 2016,41(10),2574-2584","journal-title":"Neurochem Res"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.biopsych.2016.05.011","volume":"81","author":"Lee E.","year":"2017","unstructured":"Lee E.; Lee J.; Kim E.; Excitation\/inhibition imbalance in animal models of autism spectrum disorders. Biol Psychiatry 2017,81(10),838-847","journal-title":"Biol Psychiatry"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","volume":"2","author":"Rubenstein J.L.R.","year":"2003","unstructured":"Rubenstein J.L.R.; Merzenich M.M.; Model of autism: Increased ratio of excitation\/inhibition in key neural systems. Genes Brain Behav 2003,2(5),255-267","journal-title":"Genes Brain Behav"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.tics.2006.09.003","volume":"10","author":"Tong F.","year":"2006","unstructured":"Tong F.; Meng M.; Blake R.; Neural bases of binocular rivalry. Trends Cogn Sci 2006,10(11),502-511","journal-title":"Trends Cogn Sci"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cub.2013.03.067","volume":"23","author":"van Loon A.M.","year":"2013","unstructured":"van Loon A.M.; Knapen T.; Scholte H.S.; St John-Saaltink E.; Donner T.H.; Lamme V.A.F.; GABA shapes the dynamics of bistable perception. Curr Biol 2013,23(9),823-827","journal-title":"Curr Biol"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/aur.2901","volume":"16","author":"Choi Y.B.","year":"2023","unstructured":"Choi Y.B.; Mentch J.; Haskins A.J.; Van Wicklin C.; Robertson C.E.; Visual processing in genetic conditions linked to autism: A behavioral study of binocular rivalry in individuals with 16p11.2 deletions and age\u2010matched controls. Autism Res 2023,16(4),831-840","journal-title":"Autism Res"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cub.2015.11.019","volume":"26","author":"Robertson C.E.","year":"2016","unstructured":"Robertson C.E.; Ratai E.M.; Kanwisher N.; Reduced GABAergic action in the autistic brain. Curr Biol 2016,26(1),80-85","journal-title":"Curr Biol"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2478\/v10134-010-0002-2","volume":"1","author":"Casanova M.","year":"2010","unstructured":"Casanova M.; Cortical organization. Transl Neurosci 2010,1(1),62-71","journal-title":"Transl Neurosci"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fnana.2011.00066","volume":"5","author":"Casanova M.F.","year":"2011","unstructured":"Casanova M.F.; El-Baz A.; Switala A.; Laws of conservation as related to brain growth, aging, and evolution: Symmetry of the minicolumn. Front Neuroanat 2011,5,66","journal-title":"Front Neuroanat"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00401-006-0085-5","volume":"112","author":"Casanova M.F.","year":"2006","unstructured":"Casanova M.F.; Van Kooten I.A.J.; Switala A.E.; Van Engeland H.; Heinsen H.; Steinbusch H.W.M.; Hof P.R.; Trippe J.; Stone J.; Schmitz C.; Minicolumnar abnormalities in autism. Acta Neuropathol 2006,112(3),287-303","journal-title":"Acta Neuropathol"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/brain\/awv110","volume":"138","author":"McKavanagh R.","year":"2015","unstructured":"McKavanagh R.; Buckley E.; Chance S.A.; Wider minicolumns in autism: A neural basis for altered processing? Brain 2015,138(7),2034-2045","journal-title":"Brain"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/aur.2073","volume":"12","author":"Sapey-Triomphe L.A.","year":"2019","unstructured":"Sapey-Triomphe L.A.; Lamberton F.; Soni\u00e9 S.; Mattout J.; Schmitz C.; Tactile hypersensitivity and GABA concentration in the sensorimotor cortex of adults with autism. Autism Res 2019,12(4),562-575","journal-title":"Autism Res"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/aur.2300","volume":"13","author":"Kolodny T.","year":"2020","unstructured":"Kolodny T.; Schallmo M.P.; Gerdts J.; Edden R.A.E.; Bernier R.A.; Murray S.O.; Concentrations of cortical GABA and glutamate in young adults with autism spectrum disorder. Autism Res 2020,13(7),1111-1129","journal-title":"Autism Res"},{"key":"ref=276","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1471-4159.2010.06858.x","volume":"114","author":"Oblak A.L.","year":"2010","unstructured":"Oblak A.L.; Gibbs T.T.; Blatt G.J.; Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in Autism: Decreased GABAB receptors in autism. J Neurochem 2010,114(5),1414-1423","journal-title":"J Neurochem"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/aur.88","volume":"2","author":"Oblak A.","year":"2009","unstructured":"Oblak A.; Gibbs T.T.; Blatt G.J.; Decreased GABA A receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Res 2009,2(4),205-219","journal-title":"Autism Res"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/aur.62","volume":"2","author":"Yip J.","year":"2009","unstructured":"Yip J.; Soghomonian J.J.; Blatt G.J.; Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: An in situ hybridization study. Autism Res 2009,2(1),50-59","journal-title":"Autism Res"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jnr.21520","volume":"86","author":"Yip J.","year":"2008","unstructured":"Yip J.; Soghomonian J.J.; Blatt G.J.; IncreasedGAD67 mRNA expression in cerebellar interneurons in autism: Implications for Purkinje cell dysfunction. J Neurosci Res 2008,86(3),525-530","journal-title":"J Neurosci Res"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00401-006-0176-3","volume":"113","author":"Yip J.","year":"2007","unstructured":"Yip J.; Soghomonian J.J.; Blatt G.J.; Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol 2007,113(5),559-568","journal-title":"Acta Neuropathol"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"781327","DOI":"10.3389\/fcell.2021.781327","volume":"9","author":"Zhao H.","year":"2022","unstructured":"Zhao H.; Mao X.; Zhu C.; Zou X.; Peng F.; Yang W.; Li B.; Li G.; Ge T.; Cui R.; GABAergic system dysfunction in autism spectrum disorders. Front Cell Dev Biol 2022,9,781327","journal-title":"Front Cell Dev Biol"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","volume":"87","author":"Nelson S.B.","year":"2015","unstructured":"Nelson S.B.; Valakh V.; Excitatory\/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron 2015,87(4),684-698","journal-title":"Neuron"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fncel.2014.00023","volume":"8","author":"Martin H.G.S.","year":"2014","unstructured":"Martin H.G.S.; Manzoni O.J.; Late onset deficits in synaptic plasticity in the valproic acid rat model of autism. Front Cell Neurosci 2014,8,23","journal-title":"Front Cell Neurosci"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"27400","DOI":"10.1038\/srep27400","volume":"6","author":"Iijima Y.","year":"2016","unstructured":"Iijima Y.; Behr K.; Iijima T.; Biemans B.; Bischofberger J.; Scheiffele P.; Distinct defects in synaptic differentiation of neocortical neurons in response to prenatal valproate exposure. Sci Rep 2016,6(1),27400","journal-title":"Sci Rep"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41386-018-0098-5","volume":"44","author":"Kim J.W.","year":"2019","unstructured":"Kim J.W.; Park K.; Kang R.J.; Gonzales E.L.T.; Kim D.G.; Oh H.A.; Seung H.; Ko M.J.; Kwon K.J.; Kim K.C.; Lee S.H.; Chung C.; Shin C.Y.; Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism. Neuropsychopharmacology 2019,44(2),314-323","journal-title":"Neuropsychopharmacology"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/mp.2017.213","volume":"23","author":"Brumback A.C.","year":"2018","unstructured":"Brumback A.C.; Ellwood I.T.; Kjaerby C.; Iafrati J.; Robinson S.; Lee A.T.; Patel T.; Nagaraj S.; Davatolhagh F.; Sohal V.S.; Identifying specific prefrontal neurons that contribute to autism-associated abnormalities in physiology and social behavior. Mol Psychiatry 2018,23(10),2078-2089","journal-title":"Mol Psychiatry"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.0704391104","volume":"104","author":"Rinaldi T.","year":"2007","unstructured":"Rinaldi T.; Kulangara K.; Antoniello K.; Markram H.; Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci USA 2007,104(33),13501-13506","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","volume":"2","author":"Rinaldi T.","year":"2008","unstructured":"Rinaldi T.; Perrodin C.; Markram H.; Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front Neural Circuits 2008,2,4","journal-title":"Front Neural Circuits"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/cercor\/bhm117","volume":"18","author":"Rinaldi T.","year":"2008","unstructured":"Rinaldi T.; Silberberg G.; Markram H.; Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex 2008,18(4),763-770","journal-title":"Cereb Cortex"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1017\/S1461145712001216","volume":"16","author":"Banerjee A.","year":"2013","unstructured":"Banerjee A.; Garc\u00eda-Oscos F.; Roychowdhury S.; Galindo L.C.; Hall S.; Kilgard M.P.; Atzori M.; Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism. Int J Neuropsychopharmacol 2013,16(6),1309-1318","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"860275","DOI":"10.3389\/fnmol.2022.860275","volume":"15","author":"Qi C.","year":"2022","unstructured":"Qi C.; Chen A.; Mao H.; Hu E.; Ge J.; Ma G.; Ren K.; Xue Q.; Wang W.; Wu S.; Excitatory and inhibitory synaptic imbalance caused by brain-derived neurotrophic factor deficits during development in a valproic acid mouse model of autism. Front Mol Neurosci 2022,15,860275","journal-title":"Front Mol Neurosci"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","volume":"119","author":"Bradl M.","year":"2010","unstructured":"Bradl M.; Lassmann H.; Oligodendrocytes: Biology and pathology. Acta Neuropathol 2010,119(1),37-53","journal-title":"Acta Neuropathol"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/cells8111424","volume":"8","author":"Kuhn S.","year":"2019","unstructured":"Kuhn S.; Gritti L.; Crooks D.; Dombrowski Y.; Oligodendrocytes in development, myelin generation and beyond. Cells 2019,8(11),1424","journal-title":"Cells"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/neuro.05.005.2009","volume":"3","author":"Jakovcevski I.","year":"2009","unstructured":"Jakovcevski I.; Filipovic R.; Mo Z.; Rakic S.; Zecevic N.; Oligodendrocyte development and the onset of myelination in the human fetal brain. Front Neuroanat 2009,3,5","journal-title":"Front Neuroanat"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainres.2015.10.011","volume":"1641","author":"Ackerman S.D.","year":"2016","unstructured":"Ackerman S.D.; Monk K.R.; The scales and tales of myelination: Using zebrafish and mouse to study myelinating glia. Brain Res 2016,1641(Pt A),79-91","journal-title":"Brain Res"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/aur.1243","volume":"5","author":"Travers B.G.","year":"2012","unstructured":"Travers B.G.; Adluru N.; Ennis C.; Tromp D.P.M.; Destiche D.; Doran S.; Bigler E.D.; Lange N.; Lainhart J.E.; Alexander A.L.; Diffusion tensor imaging in autism spectrum disorder: a review. Autism Res 2012,5(5),289-313","journal-title":"Autism Res"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"Chauhan A.","year":"2006","unstructured":"Chauhan A.; Chauhan V.; Oxidative stress in autism. Pathophysiology 2006,13(3),171-181","journal-title":"Pathophysiology"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1176\/appi.ajp.2016.15111435","volume":"173","author":"Ameis S.H.","year":"2016","unstructured":"Ameis S.H.; Lerch J.P.; Taylor M.J.; Lee W.; Viviano J.D.; Pipitone J.; Nazeri A.; Croarkin P.E.; Voineskos A.N.; Lai M.C.; Crosbie J.; Brian J.; Soreni N.; Schachar R.; Szatmari P.; Arnold P.D.; Anagnostou E.; A diffusion tensor imaging study in children with adhd, autism spectrum disorder, OCD, and matched controls: Distinct and non-distinct white matter disruption and dimensional brain-behavior relationships. Am J Psychiatry 2016,173(12),1213-1222","journal-title":"Am J Psychiatry"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3389\/fncel.2018.00517","volume":"12","author":"Graciarena M.","year":"2019","unstructured":"Graciarena M.; Seiffe A.; Nait-Oumesmar B.; Depino A.M.; Hypomyelination and oligodendroglial alterations in a mouse model of autism spectrum disorder. Front Cell Neurosci 2019,12,517","journal-title":"Front Cell Neurosci"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1212\/WNL.57.2.245","volume":"57","author":"Courchesne E.","year":"2001","unstructured":"Courchesne E.; Karns C.M.; Davis H.R.; Ziccardi R.; Carper R.A.; Tigue Z.D.; Chisum H.J.; Moses P.; Pierce K.; Lord C.; Lincoln A.J.; Pizzo S.; Schreibman L.; Haas R.H.; Akshoomoff N.A.; Courchesne R.Y.; Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. Neurology 2001,57(2),245-254","journal-title":"Neurology"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/cercor\/bhy348","volume":"29","author":"Dimond D.","year":"2019","unstructured":"Dimond D.; Schuetze M.; Smith R.E.; Dhollander T.; Cho I.; Vinette S.; Ten Eycke K.; Lebel C.; McCrimmon A.; Dewey D.; Connelly A.; Bray S.; Reduced white matter fiber density in autism spectrum disorder. Cereb Cortex 2019,29(4),1778-1788","journal-title":"Cereb Cortex"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/brainsci10120951","volume":"10","author":"Galvez-Contreras A.Y.","year":"2020","unstructured":"Galvez-Contreras A.Y.; Zarate-Lopez D.; Torres-Chavez A.L.; Gonzalez-Perez O.; Role of oligodendrocytes and myelin in the pathophysiology of autism spectrum disorder. Brain Sci 2020,10(12),951","journal-title":"Brain Sci"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1093\/cercor\/bhy321","volume":"29","author":"Hong S.J.","year":"2019","unstructured":"Hong S.J.; Hyung B.; Paquola C.; Bernhardt B.C.; The superficial white matter in autism and its role in connectivity anomalies and symptom severity. Cereb Cortex 2019,29(10),4415-4425","journal-title":"Cereb Cortex"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/dev.20471","volume":"52","author":"Carmody D.P.","year":"2010","unstructured":"Carmody D.P.; Lewis M.; Regional white matter development in children with autism spectrum disorders. Dev Psychobiol 2010,52(8),755-763","journal-title":"Dev Psychobiol"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2010.09.051","volume":"1362","author":"Noriuchi M.","year":"2010","unstructured":"Noriuchi M.; Kikuchi Y.; Yoshiura T.; Kira R.; Shigeto H.; Hara T.; Tobimatsu S.; Kamio Y.; Altered white matter fractional anisotropy and social impairment in children with autism spectrum disorder. Brain Res 2010,1362,141-149","journal-title":"Brain Res"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/brain\/awv118","volume":"138","author":"Wolff J.J.","year":"2015","unstructured":"Wolff J.J.; Gerig G.; Lewis J.D.; Soda T.; Styner M.A.; Vachet C.; Botteron K.N.; Elison J.T.; Dager S.R.; Estes A.M.; Hazlett H.C.; Schultz R.T.; Zwaigenbaum L.; Piven J.; Altered corpus callosum morphology associated with autism over the first 2 years of life. Brain 2015,138(7),2046-2058","journal-title":"Brain"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2011.08.020","volume":"1417","author":"Cheon K.A.","year":"2011","unstructured":"Cheon K.A.; Kim Y.S.; Oh S.H.; Park S.Y.; Yoon H.W.; Herrington J.; Nair A.; Koh Y.J.; Jang D.P.; Kim Y.B.; Leventhal B.L.; Cho Z.H.; Castellanos F.X.; Schultz R.T.; Involvement of the anterior thalamic radiation in boys with high functioning autism spectrum disorders: A Diffusion Tensor Imaging study. Brain Res 2011,1417(12),77-86","journal-title":"Brain Res"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/cercor\/bhp278","volume":"20","author":"Kumar A.","year":"2010","unstructured":"Kumar A.; Sundaram S.K.; Sivaswamy L.; Behen M.E.; Makki M.I.; Ager J.; Janisse J.; Chugani H.T.; Chugani D.C.; Alterations in frontal lobe tracts and corpus callosum in young children with autism spectrum disorder. Cereb Cortex 2010,20(9),2103-2113","journal-title":"Cereb Cortex"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pscychresns.2013.08.002","volume":"221","author":"Ikuta T.","year":"2014","unstructured":"Ikuta T.; Shafritz K.M.; Bregman J.; Peters B.D.; Gruner P.; Malhotra A.K.; Szeszko P.R.; Abnormal cingulum bundle development in autism: A probabilistic tractography study. Psychiatry Res Neuroimaging 2014,221(1),63-68","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/brain\/awt079","volume":"136","author":"Nair A.","year":"2013","unstructured":"Nair A.; Treiber J.M.; Shukla D.K.; Shih P.; M\u00fcller R.A.; Impaired thalamocortical connectivity in autism spectrum disorder: A study of functional and anatomical connectivity. Brain 2013,136(6),1942-1955","journal-title":"Brain"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13229-018-0254-0","volume":"9","author":"Bronzuoli M.R.","year":"2018","unstructured":"Bronzuoli M.R.; Facchinetti R.; Ingrassia D.; Sarvadio M.; Schiavi S.; Steardo L.; Verkhratsky A.; Trezza V.; Scuderi C.; Neuroglia in the autistic brain: Evidence from a preclinical model. Mol Autism 2018,9(1),66","journal-title":"Mol Autism"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jnc.15444","volume":"159","author":"Uccelli N.A.","year":"2021","unstructured":"Uccelli N.A.; Codagnone M.G.; Traetta M.E.; Levanovich N.; Rosato Siri M.V.; Urrutia L.; Falasco G.; V\u00e1zquez S.; Pasquini J.M.; Rein\u00e9s A.G.; Neurobiological substrates underlying corpus callosum hypoconnectivity and brain metabolic patterns in the valproic acid rat model of autism spectrum disorder. J Neurochem 2021,159(1),128-144","journal-title":"J Neurochem"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1111\/jcmm.17578","volume":"26","author":"Zhou B.","year":"2022","unstructured":"Zhou B.; Yan X.; Yang L.; Zheng X.; Chen Y.; Liu Y.; Ren Y.; Peng J.; Zhang Y.; Huang J.; Tang L.; Wen M.; Effects of arginine vasopressin on the transcriptome of prefrontal cortex in autistic rat model. J Cell Mol Med 2022,26(21),5493-5505","journal-title":"J Cell Mol Med"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"E8246","DOI":"10.1073\/pnas.1802620115","volume":"115","author":"Marie C.","year":"2018","unstructured":"Marie C.; Clavairoly A.; Frah M.; Hmidan H.; Yan J.; Zhao C.; Van Steenwinckel J.; Daveau R.; Zalc B.; Hassan B.; Thomas J.L.; Gressens P.; Ravassard P.; Moszer I.; Martin D.M.; Lu Q.R.; Parras C.; Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8. Proc Natl Acad Sci 2018,115(35),E8246-E8255","journal-title":"Proc Natl Acad Sci"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.febslet.2011.03.048","volume":"585","author":"Hanafy K.A.","year":"2011","unstructured":"Hanafy K.A.; Sloane J.A.; Regulation of remyelination in multiple sclerosis. FEBS Lett 2011,585(23),3821-3828","journal-title":"FEBS Lett"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fnbeh.2018.00230","volume":"12","author":"Boulanger-Bertolus J.","year":"2018","unstructured":"Boulanger-Bertolus J.; Pancaro C.; Mashour G.A.; Increasing role of maternal immune activation in neurodevelopmental disorders. Front Behav Neurosci 2018,12,230","journal-title":"Front Behav Neurosci"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"11516","DOI":"10.3390\/ijms222111516","volume":"22","author":"Zawadzka A.","year":"2021","unstructured":"Zawadzka A.; Cie\u015blik M.; Adamczyk A.; The role of maternal immune activation in the pathogenesis of autism: A review of the evidence, proposed mechanisms and implications for treatment. Int J Mol Sci 2021,22(21),11516","journal-title":"Int J Mol Sci"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1038\/tp.2012.61","volume":"2","author":"Rose S.","year":"2012","unstructured":"Rose S.; Melnyk S.; Pavliv O.; Bai S.; Nick T.G.; Frye R.E.; James S.J.; Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2012,2(7),e134-e134","journal-title":"Transl Psychiatry"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.immuni.2018.07.017","volume":"49","author":"Yockey L.J.","year":"2018","unstructured":"Yockey L.J.; Iwasaki A.; Interferons and proinflammatory cytokines in pregnancy and fetal development. Immunity 2018,49(3),397-412","journal-title":"Immunity"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/dneu.22052","volume":"72","author":"Fox E.","year":"2012","unstructured":"Fox E.; Amaral D.; Van de Water J.; Maternal and fetal antibrain antibodies in development and disease. Dev Neurobiol 2012,72(10),1327-1334","journal-title":"Dev Neurobiol"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1038\/tp.2011.48","volume":"1","author":"Heuer L.","year":"2011","unstructured":"Heuer L.; Braunschweig D.; Ashwood P.; Van de Water J.; Campbell D.B.; Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression. Transl Psychiatry 2011,1(10),e48-e48","journal-title":"Transl Psychiatry"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2017.07.002","volume":"299","author":"Bilbo S.D.","year":"2018","unstructured":"Bilbo S.D.; Block, C.L.; Bolton, J.L.; Hanamsagar, R.; Tran, P.K. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol 2018,299(Pt A),241-251","journal-title":"Exp Neurol"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF01531114","volume":"7","author":"Stubbs E.G.","year":"1977","unstructured":"Stubbs E.G.; Crawford M.L.; Burger D.R.; Vandenbark A.A.; Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr 1977,7(1),49-55","journal-title":"J Autism Child Schizophr"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/(SICI)1098-2779(1998)4:2<137:AID-MRDD11>3.0.CO;2-W","volume":"4","author":"Burger R.A.","year":"1998","unstructured":"Burger R.A.; Warren R.P.; Possible immunogenetic basis for autism. Ment Retard Dev Disabil Res Rev 1998,4(2),137-141","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000048665","volume":"45","author":"Croonenberghs J.","year":"2002","unstructured":"Croonenberghs J.; Bosmans E.; Deboutte D.; Kenis G.; Maes M.; Activation of the inflammatory response system in autism. Neuropsychobiology 2002,45(1),1-6","journal-title":"Neuropsychobiology"},{"key":"ref=326","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jneuroim.2005.11.007","volume":"172","author":"Molloy C.","year":"2006","unstructured":"Molloy C.; Morrow A.; Meinzenderr J.; Schleifer K.; Dienger K.; Manningcourtney P.; Altaye M.; Willskarp M.; Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006,172(1-2),198-205","journal-title":"J Neuroimmunol"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0165-5728(01)00421-0","volume":"120","author":"Jyonouchi H.","year":"2001","unstructured":"Jyonouchi H.; Sun S.; Le H.; Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001,120(1-2),170-179","journal-title":"J Neuroimmunol"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"Vargas D.L.","year":"2005","unstructured":"Vargas D.L.; Nascimbene C.; Krishnan C.; Zimmerman A.W.; Pardo C.A.; Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005,57(1),67-81","journal-title":"Ann Neurol"},{"key":"ref=329","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","volume":"68","author":"Morgan J.T.","year":"2010","unstructured":"Morgan J.T.; Chana G.; Pardo C.A.; Achim C.; Semendeferi K.; Buckwalter J.; Courchesne E.; Everall I.P.; Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 2010,68(4),368-376","journal-title":"Biol Psychiatry"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2014.09.048","volume":"1617","author":"McDougle C.J.","year":"2015","unstructured":"McDougle C.J.; Landino S.M.; Vahabzadeh A.; O\u2019Rourke J.; Zurcher N.R.; Finger B.C.; Palumbo M.L.; Helt J.; Mullett J.E.; Hooker J.M.; Carlezon W.A.; Toward an immune-mediated subtype of autism spectrum disorder. Brain Res 2015,1617,72-92","journal-title":"Brain Res"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamapsychiatry.2013.272","volume":"70","author":"Suzuki K.","year":"2013","unstructured":"Suzuki K.; Sugihara G.; Ouchi Y.; Nakamura K.; Futatsubashi M.; Takebayashi K.; Yoshihara Y.; Omata K.; Matsumoto K.; Tsuchiya K.J.; Iwata Y.; Tsujii M.; Sugiyama T.; Mori N.; Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 2013,70(1),49-58","journal-title":"JAMA Psychiatry"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbi.2012.01.015","volume":"26","author":"Oskvig D.B.","year":"2012","unstructured":"Oskvig D.B.; Elkahloun A.G.; Johnson K.R.; Phillips T.M.; Herkenham M.; Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response. Brain Behav Immun 2012,26(4),623-634","journal-title":"Brain Behav Immun"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.4049\/jimmunol.2200414","volume":"209","author":"Shook L.L.","year":"2022","unstructured":"Shook L.L.; Fourman L.T.; Edlow A.G.; Immune responses to sARS-CoV-2 in pregnancy: Implications for the health of the next generation. J Immunol 2022,209(8),1465-1473","journal-title":"J Immunol"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.3390\/ijms21093293","volume":"21","author":"Pangrazzi L.","year":"2020","unstructured":"Pangrazzi L.; Balasco L.; Bozzi Y.; Oxidative stress and immune system dysfunction in autism spectrum disorders. Int J Mol Sci 2020,21(9),3293","journal-title":"Int J Mol Sci"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.psyneuen.2016.06.001","volume":"72","author":"Kazlauskas N.","year":"2016","unstructured":"Kazlauskas N.; Campolongo M.; Lucchina L.; Zappala C.; Depino A.M.; Postnatal behavioral and inflammatory alterations in female pups prenatally exposed to valproic acid. Psychoneuroendocrinology 2016,72,11-21","journal-title":"Psychoneuroendocrinology"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.3390\/ijms21103576","volume":"21","author":"G\u0105ssowska-Dobrowolska M.","year":"2020","unstructured":"G\u0105ssowska-Dobrowolska M.; Cie\u015blik M.; Czapski G.A.; J\u0119\u015bko H.; Frontczak-Baniewicz M.; Gewartowska M.; Dominiak A.; Polowy R.; Filipkowski R.K.; Babiec L.; Adamczyk A.; Prenatal exposure to valproic acid affects microglia and synaptic ultrastructure in a brain-region-specific manner in young-adult male rats: relevance to autism spectrum disorders. Int J Mol Sci 2020,21(10),3576","journal-title":"Int J Mol Sci"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"104090","DOI":"10.1016\/j.etap.2023.104090","volume":"99","author":"Luo L.","year":"2023","unstructured":"Luo L.; Chen J.; Wu Q.; Yuan B.; Hu C.; Yang T.; Wei H.; Li T.; Prenatally VPA exposure is likely to cause autistic-like behavior in the rats offspring via TREM2 down-regulation to affect the microglial activation and synapse alterations. Environ Toxicol Pharmacol 2023,99,104090","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=338","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/toxics10070379","volume":"10","author":"Triyasakorn K.","year":"2022","unstructured":"Triyasakorn K.; Ubah U.D.B.; Roan B.; Conlin M.; Aho K.; Awale P.S.; The antiepileptic drug and toxic teratogen valproic acid alters microglia in an environmental mouse model of autism. Toxics 2022,10(7),379","journal-title":"Toxics"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000216188","volume":"16","author":"Dhabhar F.S.","year":"2009","unstructured":"Dhabhar F.S.; Enhancing versus suppressive effects of stress on immune function: Implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009,16(5),300-317","journal-title":"Neuroimmunomodulation"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.biopsych.2003.09.001","volume":"55","author":"Sweeten T.L.","year":"2004","unstructured":"Sweeten T.L.; Posey D.J.; Shankar S.; McDougle C.J.; High nitric oxide production in autistic disorder: A possible role for interferon-\u03b3. Biol Psychiatry 2004,55(4),434-437","journal-title":"Biol Psychiatry"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1089\/dna.2011.1401","volume":"31","author":"Wu C.","year":"2012","unstructured":"Wu C.; Li A.; Leng Y.; Li Y.; Kang J.; Histone deacetylase inhibition by sodium valproate regulates polarization of macrophage subsets. DNA Cell Biol 2012,31(4),592-599","journal-title":"DNA Cell Biol"},{"key":"ref=342","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neuroscience.2012.07.013","volume":"221","author":"Zhang Z.","year":"2012","unstructured":"Zhang Z.; Zhang Z.Y.; Wu Y.; Schluesener H.J.; Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats. Neuroscience 2012,221,140-150","journal-title":"Neuroscience"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12974-018-1193-6","volume":"15","author":"Chen S.","year":"2018","unstructured":"Chen S.; Ye J.; Chen X.; Shi J.; Wu W.; Lin W.; Lin W.; Li Y.; Fu H.; Li S.; Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3. J Neuroinflammation 2018,15(1),150","journal-title":"J Neuroinflammation"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/epigenomes6040038","volume":"6","author":"Ubah U.D.B.","year":"2022","unstructured":"Ubah U.D.B.; Triyasakorn K.; Roan B.; Conlin M.; Lai J.C.K.; Awale P.S.; Pan HDACi valproic acid and trichostatin a show apparently contrasting inflammatory responses in cultured J774A.1 macrophages. Epigenomes 2022,6(4),38","journal-title":"Epigenomes"},{"key":"ref=345","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00431-013-2183-4","volume":"173","author":"Noriega D.B.","year":"2014","unstructured":"Noriega D.B.; Savelkoul H.F.J.; Immune dysregulation in autism spectrum disorder. Eur J Pediatr 2014,173(1),33-43","journal-title":"Eur J Pediatr"},{"key":"ref=346","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jdn.10137","volume":"81","author":"Deckmann I.","year":"2021","unstructured":"Deckmann I.; Santos-Terra J.; Fontes-Dutra M.; K\u00f6rbes-Rockenbach M.; Bauer-Negrini G.; Schwingel G.B.; Riesgo R.; Bambini-Junior V.; Gottfried C.; Resveratrol prevents brain edema, blood\u2013brain barrier permeability, and altered aquaporin profile in autism animal model. Int J Dev Neurosci 2021,81(7),579-604","journal-title":"Int J Dev Neurosci"},{"key":"ref=347","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","volume":"64","author":"Gurvich N.","year":"2004","unstructured":"Gurvich N.; Tsygankova O.M.; Meinkoth J.L.; Klein P.S.; Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 2004,64(3),1079-1086","journal-title":"Cancer Res"},{"key":"ref=348","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrd2133","volume":"5","author":"Bolden J.E.","year":"2006","unstructured":"Bolden J.E.; Peart M.J.; Johnstone R.W.; Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006,5(9),769-784","journal-title":"Nat Rev Drug Discov"},{"key":"ref=349","first-page":"37","volume":"53","author":"Kostrouchov\u00e1 M.","year":"2007","unstructured":"Kostrouchov\u00e1 M.; Kostrouch Z.; Kostrouchov\u00e1 M.; Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol 2007,53(2),37-49","journal-title":"Folia Biol"},{"key":"ref=350","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/07391102.2014.938247","volume":"33","author":"Ganai S.A.","year":"2015","unstructured":"Ganai S.A.; Malli Kalladi S.; Mahadevan V.; HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells. J Biomol Struct Dyn 2015,33(6),1185-1197","journal-title":"J Biomol Struct Dyn"},{"key":"ref=351","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2174\/0929867023369763","volume":"9","author":"Blaheta R.A.","year":"2002","unstructured":"Blaheta R.A.; Nau H.; Michaelis M.; Cinatl J.; Valproate and valproate-analogues: Potent tools to fight against cancer. Curr Med Chem 2002,9(15),1417-1433","journal-title":"Curr Med Chem"},{"key":"ref=352","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/jcm9040966","volume":"9","author":"Yoon S.","year":"2020","unstructured":"Yoon S.; Choi J.; Lee W.; Do J.; Genetic and epigenetic etiology underlying autism spectrum disorder. J Clin Med 2020,9(4),966","journal-title":"J Clin Med"},{"key":"ref=353","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nepig.2014.10.002","volume":"1","author":"Volmar C.H.","year":"2015","unstructured":"Volmar C.H.; Wahlestedt C.; Histone deacetylases (HDACs) and brain function. Neuroepigenetics 2015,1,20-27","journal-title":"Neuroepigenetics"},{"key":"ref=354","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","volume":"22","author":"Kr\u00e4mer O.H.","year":"2003","unstructured":"Kr\u00e4mer O.H.; Zhu P.; Ostendorff H.P.; Golebiewski M.; Tiefenbach J.; Peters M.A.; Brill B.; Groner B.; Bach I.; Heinzel T.; G\u00f6ttlicher M.; The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 2003,22(13),3411-3420","journal-title":"EMBO J"},{"key":"ref=355","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"Kouzarides T.","year":"2007","unstructured":"Kouzarides T.; Chromatin modifications and their function. Cell 2007,128(4),693-705","journal-title":"Cell"},{"key":"ref=356","doi-asserted-by":"publisher","first-page":"35977","DOI":"10.1074\/jbc.M111.266254","volume":"286","author":"Hezroni H.","year":"2011","unstructured":"Hezroni H.; Sailaja B.S.; Meshorer E.; Pluripotency-related, valproic acid (VPA)-induced genome-wide histone H3 lysine 9 (H3K9) acetylation patterns in embryonic stem cells. J Biol Chem 2011,286(41),35977-35988","journal-title":"J Biol Chem"},{"key":"ref=357","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/gene.10250","volume":"38","author":"Lee JH","year":"2004","unstructured":"Lee JH; Hart SRL; Skalnik DG; Histone deacetylase activity is required for embryonic stem cell differentiation. genesis 2004,38(1),32-38","journal-title":"genesis"},{"key":"ref=358","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1074\/jbc.M114.603761","volume":"290","author":"Qiao Y.","year":"2015","unstructured":"Qiao Y.; Wang R.; Yang X.; Tang K.; Jing N.; Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation. J Biol Chem 2015,290(4),2508-2520","journal-title":"J Biol Chem"},{"key":"ref=359","doi-asserted-by":"publisher","first-page":"e202201433","DOI":"10.26508\/lsa.202201433","volume":"5","author":"Gandhi S.","year":"2022","unstructured":"Gandhi S.; Mitterhoff R.; Rapoport R.; Farago M.; Greenberg A.; Hodge L.; Eden S.; Benner C.; Goren A.; Simon I.; Mitotic H3K9ac is controlled by phase-specific activity of HDAC2, HDAC3, and SIRT1. Life Sci Alliance 2022,5(10),e202201433","journal-title":"Life Sci Alliance"},{"key":"ref=360","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","volume":"21","author":"Lagger G.","year":"2002","unstructured":"Lagger G.; O\u2019Carroll D.; Rembold M.; Khier H.; Tischler J.; Weitzer G.; Schuettengruber B.; Hauser C.; Brunmeir R.; Jenuwein T.; Seiser C.; Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 2002,21(11),2672-2681","journal-title":"EMBO J"},{"key":"ref=361","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5607\/en.2017.26.5.252","volume":"26","author":"Kim K.C.","year":"2017","unstructured":"Kim K.C.; Choi C.S.; Gonzales E.L.T.; Mabunga D.F.N.; Lee S.H.; Jeon S.J.; Hwangbo R.; Hong M.; Ryu J.H.; Han S.H.; Bahn G.H.; Shin C.Y.; Valproic acid induces telomerase reverse transcriptase expression during cortical development. Exp Neurobiol 2017,26(5),252-265","journal-title":"Exp Neurobiol"},{"key":"ref=362","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.taap.2010.08.001","volume":"248","author":"Tung E.W.Y.","year":"2010","unstructured":"Tung E.W.Y.; Winn L.M.; Epigenetic modifications in valproic acid-induced teratogenesis. Toxicol Appl Pharmacol 2010,248(3),201-209","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=363","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/ar.21232","volume":"293","author":"Wang Z.","year":"2010","unstructured":"Wang Z.; Xu L.; Zhu X.; Cui W.; Sun Y.; Nishijo H.; Peng Y.; Li R.; Demethylation of specific Wnt\/\u03b2-catenin pathway genes and its upregulation in rat brain induced by prenatal valproate exposure. Anat Rec 2010,293(11),1947-1953","journal-title":"Anat Rec"},{"key":"ref=364","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/emm.2014.18","volume":"46","author":"He Y.","year":"2014","unstructured":"He Y.; Mei H.; Yu H.; Sun S.; Ni W.; Li H.; Role of histone deacetylase activity in the developing lateral line neuromast of zebrafish larvae. Exp Mol Med 2014,46(5),e94-e94","journal-title":"Exp Mol Med"},{"key":"ref=365","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/hmg\/ddad002","volume":"32","author":"Leung C.S.","year":"2023","unstructured":"Leung C.S.; Rosenzweig S.J.; Yoon B.; Marinelli N.A.; Hollingsworth E.W.; Maguire A.M.; Cowen M.H.; Schmidt M.; Imitola J.; Gamsiz Uzun E.D.; Lizarraga S.B.; Dysregulation of the chromatin environment leads to differential alternative splicing as a mechanism of disease in a human model of autism spectrum disorder. Hum Mol Genet 2023,32(10),1634-1646","journal-title":"Hum Mol Genet"},{"key":"ref=366","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1756-8935-6-11","volume":"6","author":"Boudadi E.","year":"2013","unstructured":"Boudadi E.; Stower H.; Halsall J.A.; Rutledge C.E.; Leeb M.; Wutz A.; O\u2019Neill L.P.; Nightingale K.P.; Turner B.M.; The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing. Epigenetics Chromatin 2013,6(1),11","journal-title":"Epigenetics Chromatin"},{"key":"ref=367","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41398-023-02391-9","volume":"13","author":"Guerra M.","year":"2023","unstructured":"Guerra M.; Medici V.; Weatheritt R.; Corvino V.; Palacios D.; Geloso M.C.; Farini D.; Sette C.; Fetal exposure to valproic acid dysregulates the expression of autism-linked genes in the developing cerebellum. Transl Psychiatry 2023,13(1),114","journal-title":"Transl Psychiatry"},{"key":"ref=368","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13229-017-0149-5","volume":"8","author":"Hara Y.","year":"2017","unstructured":"Hara Y.; Ago Y.; Takano E.; Hasebe S.; Nakazawa T.; Hashimoto H.; Matsuda T.; Takuma K.; Prenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brain. Mol Autism 2017,8(1),33","journal-title":"Mol Autism"},{"key":"ref=369","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2121-9-66","volume":"9","author":"Jung G.A.","year":"2008","unstructured":"Jung G.A.; Yoon J.Y.; Moon B.S.; Yang D.H.; Kim H.Y.; Lee S.H.; Bryja V.; Arenas E.; Choi K.Y.; Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip\/WAF1 pathway. BMC Cell Biol 2008,9(1),66","journal-title":"BMC Cell Biol"},{"key":"ref=370","doi-asserted-by":"publisher","first-page":"D832","DOI":"10.1093\/nar\/gkn835","volume":"37","author":"Basu S.N.","year":"2009","unstructured":"Basu S.N.; Kollu R.; Banerjee-Basu S.; AutDB: a gene reference resource for autism research. Nucleic Acids Res 2009,37(Database issue),D832-D836","journal-title":"Nucleic Acids Res"},{"key":"ref=371","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13072-021-00432-5","volume":"14","author":"Baumann C.","year":"2021","unstructured":"Baumann C.; Zhang X.; Zhu L.; Fan Y.; De La Fuente R.; Changes in chromatin accessibility landscape and histone H3 core acetylation during valproic acid-induced differentiation of embryonic stem cells. Epigenetics Chromatin 2021,14(1),58","journal-title":"Epigenetics Chromatin"},{"key":"ref=372","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.4161\/cc.8.11.8620","volume":"8","author":"Yuan J.","year":"2009","unstructured":"Yuan J.; Pu M.; Zhang Z.; Lou Z.; Histone H3-K56 acetylation is important for genomic stability in mammals. Cell Cycle 2009,8(11),1747-1753","journal-title":"Cell Cycle"},{"key":"ref=373","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"Tessarz P.","year":"2014","unstructured":"Tessarz P.; Kouzarides T.; Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol 2014,15(11),703-708","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=374","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.molcel.2009.02.004","volume":"33","author":"Xie W.","year":"2009","unstructured":"Xie W.; Song C.; Young N.L.; Sperling A.S.; Xu F.; Sridharan R.; Conway A.E.; Garcia B.A.; Plath K.; Clark A.T.; Grunstein M.; Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell 2009,33(4),417-427","journal-title":"Mol Cell"},{"key":"ref=375","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1634\/stemcells.2007-0884","volume":"26","author":"Osumi N.","year":"2008","unstructured":"Osumi N.; Shinohara H.; Numayama-Tsuruta K.; Maekawa M.; Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator. Stem Cells 2008,26(7),1663-1672","journal-title":"Stem Cells"},{"key":"ref=376","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00429-012-0397-2","volume":"218","author":"Duan D.","year":"2013","unstructured":"Duan D.; Fu Y.; Paxinos G.; Watson C.; Spatiotemporal expression patterns of Pax6 in the brain of embryonic, newborn, and adult mice. Brain Struct Funct 2013,218(2),353-372","journal-title":"Brain Struct Funct"},{"key":"ref=377","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1073\/pnas.0500819102","volume":"102","author":"Kroll T.T.","year":"2005","unstructured":"Kroll T.T.; O\u2019Leary D.D.M.; Ventralized dorsal telencephalic progenitors in Pax6 mutant mice generate GABA interneurons of a lateral ganglionic eminence fate. Proc Natl Acad Sci 2005,102(20),7374-7379","journal-title":"Proc Natl Acad Sci"},{"key":"ref=378","doi-asserted-by":"publisher","first-page":"e1000511","DOI":"10.1371\/journal.pgen.1000511","volume":"5","author":"Sansom S.N.","year":"2009","unstructured":"Sansom S.N.; Griffiths D.S.; Faedo A.; Kleinjan D.J.; Ruan Y.; Smith J.; The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis. PLoS Genet 2009,5(6),e1000511","journal-title":"PLoS Genet"},{"key":"ref=379","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.07.003","volume":"493","author":"Yuan X.","year":"2020","unstructured":"Yuan X.; Dai M.; Xu D.; TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends. Cancer Lett 2020,493,1-9","journal-title":"Cancer Lett"},{"key":"ref=380","doi-asserted-by":"publisher","first-page":"11493","DOI":"10.1073\/pnas.1309914110","volume":"110","author":"Tan Y.","year":"2013","unstructured":"Tan Y.; Xue Y.; Song C.; Grunstein M.; Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency. Proc Natl Acad Sci 2013,110(28),11493-11498","journal-title":"Proc Natl Acad Sci"},{"key":"ref=381","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nn.2333","volume":"12","author":"Ye F.","year":"2009","unstructured":"Ye F.; Chen Y.; Hoang T.; Montgomery R.L.; Zhao X.; Bu H.; Hu T.; Taketo M.M.; van Es J.H.; Clevers H.; Hsieh J.; Bassel-Duby R.; Olson E.N.; Lu Q.R.; HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the \u03b2-catenin-TCF interaction. Nat Neurosci 2009,12(7),829-838","journal-title":"Nat Neurosci"},{"key":"ref=382","doi-asserted-by":"publisher","first-page":"e50958","DOI":"10.15252\/embr.202050958","volume":"22","author":"Jamadagni P.","year":"2021","unstructured":"Jamadagni P.; Breuer M.; Schmeisser K.; Cardinal T.; Kassa B.; Parker J.A.; Pilon N.; Samarut E.; Patten S.A.; Chromatin remodeller CHD7 is required for GABAergic neuron development by promoting PAQR3 expression. EMBO Rep 2021,22(6),e50958","journal-title":"EMBO Rep"},{"key":"ref=383","doi-asserted-by":"publisher","first-page":"645518","DOI":"10.3389\/fcell.2021.645518","volume":"9","author":"Mello M.L.S.","year":"2021","unstructured":"Mello M.L.S.; Sodium Valproate-Induced Chromatin Remodeling. Front Cell Dev Biol 2021,9,645518","journal-title":"Front Cell Dev Biol"},{"key":"ref=384","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1073\/pnas.0510341103","volume":"103","author":"Simonini M.V.","year":"2006","unstructured":"Simonini M.V.; Camargo L.M.; Dong E.; Maloku E.; Veldic M.; Costa E.; Guidotti A.; The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci 2006,103(5),1587-1592","journal-title":"Proc Natl Acad Sci"},{"key":"ref=385","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1073\/pnas.0700529104","volume":"104","author":"Dong E.","year":"2007","unstructured":"Dong E.; Guidotti A.; Grayson D.R.; Costa E.; Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci 2007,104(11),4676-4681","journal-title":"Proc Natl Acad Sci"},{"key":"ref=386","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1073\/pnas.262658999","volume":"99","author":"Tremolizzo L.","year":"2002","unstructured":"Tremolizzo L.; Carboni G.; Ruzicka W.B.; Mitchell C.P.; Sugaya I.; Tueting P.; Sharma R.; Grayson D.R.; Costa E.; Guidotti A.; An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci 2002,99(26),17095-17100","journal-title":"Proc Natl Acad Sci"},{"key":"ref=387","doi-asserted-by":"publisher","first-page":"18236","DOI":"10.1038\/s41598-019-54848-x","volume":"9","author":"Rocha M.A.","year":"2019","unstructured":"Rocha M.A.; Veronezi G.M.B.; Felisbino M.B.; Gatti M.S.V.; Tamashiro W.M.S.C.; Mello M.L.S.; Sodium valproate and 5-aza-2\u2032-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells. Sci Rep 2019,9(1),18236","journal-title":"Sci Rep"},{"key":"ref=388","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1158\/0008-5472.CAN-04-2478","volume":"65","author":"Marchion D.C.","year":"2005","unstructured":"Marchion D.C.; Bicaku E.; Daud A.I.; Sullivan D.M.; Munster P.N.; Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res 2005,65(9),3815-3822","journal-title":"Cancer Res"},{"key":"ref=389","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exer.2014.01.021","volume":"121","author":"Palsamy P.","year":"2014","unstructured":"Palsamy P.; Bidasee K.R.; Shinohara T.; Valproic acid suppresses Nrf2\/Keap1 dependent antioxidant protection through induction of endoplasmic reticulum stress and Keap1 promoter DNA demethylation in human lens epithelial cells. Exp Eye Res 2014,121,26-34","journal-title":"Exp Eye Res"},{"key":"ref=390","doi-asserted-by":"publisher","first-page":"27586","DOI":"10.1074\/jbc.M303740200","volume":"278","author":"Detich N.","year":"2003","unstructured":"Detich N.; Bovenzi V.; Szyf M.; Valproate induces replication-independent active DNA demethylation. J Biol Chem 2003,278(30),27586-27592","journal-title":"J Biol Chem"},{"key":"ref=391","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/carcin\/bgl167","volume":"28","author":"Milutinovic S.","year":"2007","unstructured":"Milutinovic S.; D\u2019Alessio A.C.; Detich N.; Szyf M.; Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 2007,28(3),560-571","journal-title":"Carcinogenesis"},{"key":"ref=392","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4161\/epi.5.8.13053","volume":"5","author":"Dong E.","year":"2010","unstructured":"Dong E.; Chen Y.; Gavin D.P.; Grayson D.R.; Guidotti A.; Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics 2010,5(8),730-735","journal-title":"Epigenetics"},{"key":"ref=393","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s12035-016-9871-9","volume":"54","author":"Tan N.N.","year":"2017","unstructured":"Tan N.N.; Tang H.L.; Lin G.W.; Chen Y.H.; Lu P.; Li H.J.; Gao M.M.; Zhao Q.H.; Yi Y.H.; Liao W.P.; Long Y.S.; Epigenetic downregulation of scn3a expression by valproate: A possible role in its anticonvulsant activity. Mol Neurobiol 2017,54(4),2831-2842","journal-title":"Mol Neurobiol"},{"key":"ref=394","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-022-01078-9","volume":"7","author":"Park J.","year":"2022","unstructured":"Park J.; Lee K.; Kim K.; Yi S.J.; The role of histone modifications: From neurodevelopment to neurodiseases. Signal Transduct Target Ther 2022,7(1),217","journal-title":"Signal Transduct Target Ther"},{"key":"ref=395","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"G\u00f6ttlicher M.","year":"2001","unstructured":"G\u00f6ttlicher M.; Minucci S.; Zhu P.; Kr\u00e4mer O.H.; Schimpf A.; Giavara S.; Sleeman J.P.; Lo Coco F.; Nervi C.; Pelicci P.G.; Heinzel T.; Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001,20(24),6969-6978","journal-title":"EMBO J"},{"key":"ref=396","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41580-018-0076-0","volume":"20","author":"Emmett M.J.","year":"2019","unstructured":"Emmett M.J.; Lazar M.A.; Integrative regulation of physiology by histone deacetylase 3. Nat Rev Mol Cell Biol 2019,20(2),102-115","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=397","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/129383","volume":"2011","author":"Hayakawa T.","year":"2011","unstructured":"Hayakawa T.; Nakayama J.; Physiological roles of class I HDAC complex and histone demethylase. J Biomed Biotechnol 2011,2011,1-10","journal-title":"J Biomed Biotechnol"},{"key":"ref=398","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/1874467215666220316110405","volume":"16","author":"Mello M.L.S.","year":"2023","unstructured":"Mello M.L.S.; Rocha M.A.; de Campos V.B.; Sodium valproate modulates the methylation status of lysine residues 4, 9 and 27 in histone H3 of HeLa cells. Curr Mol Pharmacol 2023,16(2),197-210","journal-title":"Curr Mol Pharmacol"},{"key":"ref=399","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.neuropharm.2010.09.022","volume":"60","author":"Marinova Z.","year":"2011","unstructured":"Marinova Z.; Leng Y.; Leeds P.; Chuang D.M.; Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons. Neuropharmacology 2011,60(7-8),1109-1115","journal-title":"Neuropharmacology"},{"key":"ref=400","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1074\/jbc.M606773200","volume":"282","author":"Nightingale K.P.","year":"2007","unstructured":"Nightingale K.P.; Gendreizig S.; White D.A.; Bradbury C.; Hollfelder F.; Turner B.M.; Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem 2007,282(7),4408-4416","journal-title":"J Biol Chem"},{"key":"ref=401","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1093\/nar\/gkz292","volume":"47","author":"Rahhal R.","year":"2019","unstructured":"Rahhal R.; Seto E.; Emerging roles of histone modifications and HDACs in RNA splicing. Nucleic Acids Res 2019,47(10),4911-4926","journal-title":"Nucleic Acids Res"},{"key":"ref=402","doi-asserted-by":"publisher","first-page":"e16727","DOI":"10.1371\/journal.pone.0016727","volume":"6","author":"Hnilicov\u00e1 J.","year":"2011","unstructured":"Hnilicov\u00e1 J.; Hozeifi S.; Du\u0161kov\u00e1 E.; Icha J.; Tom\u00e1nkov\u00e1 T.; Stan\u011bk D.; Histone deacetylase activity modulates alternative splicing. PLoS One 2011,6(2),e16727","journal-title":"PLoS One"},{"key":"ref=403","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fmolb.2018.00012","volume":"5","author":"Su C.H.","year":"2018","unstructured":"Su C.H.; D, D.; Tarn, W.Y. Alternative splicing in neurogenesis and brain development. Front Mol Biosci 2018,5,12","journal-title":"Front Mol Biosci"},{"key":"ref=404","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tig.2022.06.001","volume":"38","author":"Engal E.","year":"2022","unstructured":"Engal E.; Baker M.; Salton M.; The chromatin roots of abnormal splicing in autism. Trends Genet 2022,38(9),892-894","journal-title":"Trends Genet"},{"key":"ref=405","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cell.2016.10.031","volume":"167","author":"Sun W.","year":"2016","unstructured":"Sun W.; Poschmann J.; Cruz-Herrera del Rosario R.; Parikshak N.N.; Hajan H.S.; Kumar V.; Ramasamy R.; Belgard T.G.; Elanggovan B.; Wong C.C.Y.; Mill J.; Geschwind D.H.; Prabhakar S.; Histone acetylome-wide association study of autism spectrum disorder. Cell 2016,167(5),1385-1397.e11","journal-title":"Cell"},{"key":"ref=406","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21608\/rpbs.2023.189540.1205","volume":"7","author":"Elgamal M.","year":"2023","unstructured":"Elgamal M.; Moustafa Y.; Ali A.; El-Sayed N.; Khodeer D.; Mechanisms of valproic acid-induced autism: Canonical wnt-\u03b2- catenin pathway. Records of Pharmaceutical and Biomedical Sciences 2023,7(3),51-62","journal-title":"Records of Pharmaceutical and Biomedical Sciences"},{"key":"ref=407","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s11481-012-9404-x","volume":"7","author":"Mulligan K.A.","year":"2012","unstructured":"Mulligan K.A.; Cheyette B.N.R.; Wnt signaling in vertebrate neural development and function. J Neuroimmune Pharmacol 2012,7(4),774-787","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=408","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fncel.2013.00103","volume":"7","author":"Rosso S.B.","year":"2013","unstructured":"Rosso S.B.; Inestrosa N.C.; WNT signaling in neuronal maturation and synaptogenesis. Front Cell Neurosci 2013,7,103","journal-title":"Front Cell Neurosci"},{"key":"ref=409","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s11689-016-9176-3","volume":"8","author":"Kwan V.","year":"2016","unstructured":"Kwan V.; Unda B.K.; Singh K.K.; Wnt signaling networks in autism spectrum disorder and intellectual disability. J Neurodev Disord 2016,8(1),45","journal-title":"J Neurodev Disord"},{"key":"ref=410","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"Phiel C.J.","year":"2001","unstructured":"Phiel C.J.; Zhang F.; Huang E.Y.; Guenther M.G.; Lazar M.A.; Klein P.S.; Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001,276(39),36734-36741","journal-title":"J Biol Chem"},{"key":"ref=411","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1158\/1078-0432.CCR-03-0100","volume":"10","author":"Takai N.","year":"2004","unstructured":"Takai N.; Desmond J.C.; Kumagai T.; Gui D.; Said J.W.; Whittaker S.; Miyakawa I.; Koeffler H.P.; Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Clin Cancer Res 2004,10(3),1141-1149","journal-title":"Clin Cancer Res"},{"key":"ref=412","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2005.02.002","volume":"55","author":"Digel W.","year":"2005","unstructured":"Digel W.; L\u00fcbbert M.; DNA methylation disturbances as novel therapeutic target in lung cancer: Preclinical and clinical results. Crit Rev Oncol Hematol 2005,55(1),1-11","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=413","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3389\/fonc.2020.01341","volume":"10","author":"Nie X.","year":"2020","unstructured":"Nie X.; Liu H.; Liu L.; Wang Y.D.; Chen W.D.; Emerging roles of Wnt ligands in human colorectal cancer. Front Oncol 2020,10,1341","journal-title":"Front Oncol"},{"key":"ref=414","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s11689-019-9268-y","volume":"11","author":"Kumar S.","year":"2019","unstructured":"Kumar S.; Reynolds K.; Ji Y.; Gu R.; Rai S.; Zhou C.J.; Impaired neurodevelopmental pathways in autism spectrum disorder: A review of signaling mechanisms and crosstalk. J Neurodev Disord 2019,11(1),10","journal-title":"J Neurodev Disord"},{"key":"ref=415","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1038\/tp.2013.75","volume":"3","author":"Martin P-M.","year":"2013","unstructured":"Martin P-M.; Yang X.; Robin N.; Lam E.; Rabinowitz J.S.; Erdman C.A.; Quinn J.; Weiss L.A.; Hamilton S.P.; Kwok P-Y.; Moon R.T.; Cheyette B.N.R.; A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation. Transl Psychiatry 2013,3(9),e301-e301","journal-title":"Transl Psychiatry"},{"key":"ref=416","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ajmg.1401","volume":"105","author":"Wassink T.H.","year":"2001","unstructured":"Wassink T.H.; Piven J.; Vieland V.J.; Huang J.; Swiderski R.E.; Pietila J.; Braun T.; Beck G.; Folstein S.E.; Haines J.L.; Sheffield V.C.; Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet 2001,105(5),406-413","journal-title":"Am J Med Genet"},{"key":"ref=417","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1017\/S1461145709990903","volume":"13","author":"Marui T.","year":"2010","unstructured":"Marui T.; Funatogawa I.; Koishi S.; Yamamoto K.; Matsumoto H.; Hashimoto O.; Jinde S.; Nishida H.; Sugiyama T.; Kasai K.; Watanabe K.; Kano Y.; Kato N.; Association between autism and variants in the wingless-type MMTV integration site family member 2 (WNT2) gene. Int J Neuropsychopharmacol 2010,13(4),443-449","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=418","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.neuron.2011.05.015","volume":"70","author":"Levy D.","year":"2011","unstructured":"Levy D.; Ronemus M.; Yamrom B.; Lee Y.; Leotta A.; Kendall J.; Marks S.; Lakshmi B.; Pai D.; Ye K.; Buja A.; Krieger A.; Yoon S.; Troge J.; Rodgers L.; Iossifov I.; Wigler M.; Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011,70(5),886-897","journal-title":"Neuron"},{"key":"ref=419","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ridd.2012.03.004","volume":"33","author":"Lin P.I.","year":"2012","unstructured":"Lin P.I.; Chien Y.L.; Wu Y.Y.; Chen C.H.; Gau S.S.F.; Huang Y.S.; Liu S.K.; Tsai W.C.; Chiu Y.N.; The WNT2 gene polymorphism associated with speech delay inherent to autism. Res Dev Disabil 2012,33(5),1533-1540","journal-title":"Res Dev Disabil"},{"key":"ref=420","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tins.2013.11.005","volume":"37","author":"Krumm N.","year":"2014","unstructured":"Krumm N.; O\u2019Roak B.J.; Shendure J.; Eichler E.E.; A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci 2014,37(2),95-105","journal-title":"Trends Neurosci"},{"key":"ref=421","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.celrep.2017.03.052","volume":"19","author":"Platt R.J.","year":"2017","unstructured":"Platt R.J.; Zhou Y.; Slaymaker I.M.; Shetty A.S.; Weisbach N.R.; Kim J.A.; Sharma J.; Desai M.; Sood S.; Kempton H.R.; Crabtree G.R.; Feng G.; Zhang F.; Chd8 mutation leads to autistic-like behaviors and impaired striatal circuits. Cell Rep 2017,19(2),335-350","journal-title":"Cell Rep"},{"key":"ref=422","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1128\/MCB.00322-08","volume":"28","author":"Thompson B.A.","year":"2008","unstructured":"Thompson B.A.; Tremblay V.; Lin G.; Bochar D.A.; CHD8 is an ATP-dependent chromatin remodeling factor that regulates \u03b2-catenin target genes. Mol Cell Biol 2008,28(12),3894-3904","journal-title":"Mol Cell Biol"},{"key":"ref=423","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/aur.132","volume":"3","author":"McBride K.L.","year":"2010","unstructured":"McBride K.L.; Varga E.A.; Pastore M.T.; Prior T.W.; Manickam K.; Atkin J.F.; Herman G.E.; Confirmation study of PTEN mutations among individuals with autism or developmental delays\/mental retardation and macrocephaly. Autism Res 2010,3(3),137-141","journal-title":"Autism Res"},{"key":"ref=424","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00125-011-2314-2","volume":"55","author":"Zhou T.","year":"2012","unstructured":"Zhou T.; He X.; Cheng R.; Zhang B.; Zhang R.R.; Chen Y.; Takahashi Y.; Murray A.R.; Lee K.; Gao G.; Ma J.; Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 2012,55(1),255-266","journal-title":"Diabetologia"},{"key":"ref=425","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.tins.2021.08.007","volume":"44","author":"DeSpenza T.","year":"2021","unstructured":"DeSpenza T.; Carlson M.; Panchagnula S.; Robert S.; Duy P.Q.; Mermin-Bunnell N.; Reeves B.C.; Kundishora A.; Elsamadicy A.A.; Smith H.; Ocken J.; Alper S.L.; Jin S.C.; Hoffman E.J.; Kahle K.T.; PTEN mutations in autism spectrum disorder and congenital hydrocephalus: developmental pleiotropy and therapeutic targets. Trends Neurosci 2021,44(12),961-976","journal-title":"Trends Neurosci"},{"key":"ref=426","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.phrs.2017.08.006","volume":"128","author":"Mahmood U.","year":"2018","unstructured":"Mahmood U.; Ahn S.; Yang E.J.; Choi M.; Kim H.; Regan P.; Cho K.; Kim H.S.; Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder. Pharmacol Res 2018,128,110-121","journal-title":"Pharmacol Res"},{"key":"ref=427","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40478-015-0184-4","volume":"3","author":"Nicolini C.","year":"2015","unstructured":"Nicolini C.; Ahn Y.; Michalski B.; Rho J.M.; Fahnestock M.; Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol Commun 2015,3(1),3","journal-title":"Acta Neuropathol Commun"},{"key":"ref=428","doi-asserted-by":"publisher","first-page":"e0153298","DOI":"10.1371\/journal.pone.0153298","volume":"11","author":"Yang E.J.","year":"2016","unstructured":"Yang E.J.; Ahn S.; Lee K.; Mahmood U.; Kim H.S.; Early behavioral abnormalities and perinatal alterations of PTEN\/AKT pathway in valproic acid autism model mice. PLoS One 2016,11(4),e0153298","journal-title":"PLoS One"},{"key":"ref=429","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13229-017-0160-x","volume":"8","author":"Barrett C.E.","year":"2017","unstructured":"Barrett C.E.; Hennessey T.M.; Gordon K.M.; Ryan S.J.; McNair M.L.; Ressler K.J.; Rainnie D.G.; Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally. Mol Autism 2017,8(1),42","journal-title":"Mol Autism"},{"key":"ref=430","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1124\/mol.111.072314","volume":"80","author":"Tung E.W.Y.","year":"2011","unstructured":"Tung E.W.Y.; Winn L.M.; Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: A role for oxidative stress in valproic acid-induced neural tube defects. Mol Pharmacol 2011,80(6),979-987","journal-title":"Mol Pharmacol"},{"key":"ref=431","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/nn.4420","volume":"19","author":"Sztainberg Y.","year":"2016","unstructured":"Sztainberg Y.; Zoghbi H.Y.; Lessons learned from studying syndromic autism spectrum disorders. Nat Neurosci 2016,19(11),1408-1417","journal-title":"Nat Neurosci"},{"key":"ref=432","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-017-1736-4","volume":"134","author":"Varghese M.","year":"2017","unstructured":"Varghese M.; Keshav N.; Jacot-Descombes S.; Warda T.; Wicinski B.; Dickstein, DL Autism spectrum disorder: Neuropathology and animal models. Acta Neuropathol 2017,134(4),537-566","journal-title":"Acta Neuropathol"},{"key":"ref=433","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4062\/biomolther.2016.061","volume":"24","author":"Kim K.C.","year":"2016","unstructured":"Kim K.C.; Gonzales E.L.; L\u00e1zaro M.T.; Choi C.S.; Bahn G.H.; Yoo H.J.; Shin C.Y.; Clinical and neurobiological relevance of current animal models of autism spectrum disorders. Biomol Ther 2016,24(3),207-243","journal-title":"Biomol Ther"},{"key":"ref=434","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrg3142","volume":"13","author":"Feil R.","year":"2012","unstructured":"Feil R.; Fraga M.F.; Epigenetics and the environment: Emerging patterns and implications. Nat Rev Genet 2012,13(2),97-109","journal-title":"Nat Rev Genet"},{"key":"ref=435","doi-asserted-by":"publisher","first-page":"620859","DOI":"10.3389\/fgene.2021.620859","volume":"12","author":"Good K.V.","year":"2021","unstructured":"Good K.V.; Vincent J.B.; Ausi\u00f3 J.; MeCP2: The genetic driver of rett syndrome epigenetics. Front Genet 2021,12,620859","journal-title":"Front Genet"},{"key":"ref=436","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fneur.2015.00107","volume":"6","author":"Loke Y.J.","year":"2015","unstructured":"Loke Y.J.; Hannan A.J.; Craig J.M.; The role of epigenetic change in autism spectrum disorders. Front Neurol 2015,6,107","journal-title":"Front Neurol"},{"key":"ref=437","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.1038\/s41380-021-01199-7","volume":"26","author":"Balan S.","year":"2021","unstructured":"Balan S.; Iwayama Y.; Ohnishi T.; Fukuda M.; Shirai A.; Yamada A.; Weirich S.; Schuhmacher M.K.; Dileep K.V.; Endo T.; Hisano Y.; Kotoshiba K.; Toyota T.; Otowa T.; Kuwabara H.; Tochigi M.; Watanabe A.; Ohba H.; Maekawa M.; Toyoshima M.; Sasaki T.; Nakamura K.; Tsujii M.; Matsuzaki H.; Zhang K.Y.J.; Jeltsch A.; Shinkai Y.; Yoshikawa T.; A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin \u03b2-cluster genes in the developing brain. Mol Psychiatry 2021,26(12),7550-7559","journal-title":"Mol Psychiatry"},{"key":"ref=438","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbr.2009.11.008","volume":"208","author":"Balemans M.C.M.","year":"2010","unstructured":"Balemans M.C.M.; Huibers M.M.H.; Eikelenboom N.W.D.; Kuipers A.J.; van Summeren R.C.J.; Pijpers M.M.C.A.; Tachibana M.; Shinkai Y.; van Bokhoven H.; Van der Zee C.E.E.M.; Reduced exploration, increased anxiety, and altered social behavior: Autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice. Behav Brain Res 2010,208(1),47-55","journal-title":"Behav Brain Res"},{"key":"ref=439","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ajhg.2014.09.013","volume":"95","author":"Chen E.S.","year":"2014","unstructured":"Chen E.S.; Gigek C.O.; Rosenfeld J.A.; Diallo A.B.; Maussion G.; Chen G.G.; Vaillancourt K.; Lopez J.P.; Crapper L.; Poujol R.; Shaffer L.G.; Bourque G.; Ernst C.; Molecular convergence of neurodevelopmental disorders. Am J Hum Genet 2014,95(5),490-508","journal-title":"Am J Hum Genet"},{"key":"ref=440","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1038\/s41380-022-01566-y","volume":"27","author":"Lin C.W.","year":"2022","unstructured":"Lin C.W.; Septyaningtrias D.E.; Chao H.W.; Konda M.; Atarashi K.; Takeshita K.; Tamada K.; Nomura J.; Sasagawa Y.; Tanaka K.; Nikaido I.; Honda K.; McHugh T.J.; Takumi T.; A common epigenetic mechanism across different cellular origins underlies systemic immune dysregulation in an idiopathic autism mouse model. Mol Psychiatry 2022,27(8),3343-3354","journal-title":"Mol Psychiatry"},{"key":"ref=441","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-01999-z","author":"Lin C.W.","year":"2023","unstructured":"Lin C.W.; Ellegood J.; Tamada K.; Miura I.; Konda M.; Takeshita K.; An old model with new insights: Endogenous retroviruses drive the evolvement toward ASD susceptibility and hijack transcription machinery during development. Mol Psychiatry (Epub a head of print).2023","journal-title":"Mol Psychiatry"},{"key":"ref=442","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.biopsych.2021.11.021","volume":"91","author":"Tseng C.E.J.","year":"2022","unstructured":"Tseng C.E.J.; McDougle C.J.; Hooker J.M.; Z\u00fcrcher N.R.; Epigenetics of autism spectrum disorder: Histone deacetylases. Biol Psychiatry 2022,91(11),922-933","journal-title":"Biol Psychiatry"},{"key":"ref=443","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/ijms17060842","volume":"17","author":"Cao D.D.","year":"2016","unstructured":"Cao D.D.; Li L.; Chan W.Y.; MicroRNAs: Key regulators in the central nervous system and their implication in neurological diseases. Int J Mol Sci 2016,17(6),842","journal-title":"Int J Mol Sci"},{"key":"ref=444","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fcell.2020.00763","volume":"8","author":"Pejhan S.","year":"2020","unstructured":"Pejhan S.; Del Bigio M.R.; Rastegar M.; The MeCP2E1\/E2-BDNF-miR132 homeostasis regulatory network is region-dependent in the human brain and is impaired in rett syndrome patients. Front Cell Dev Biol 2020,8,763","journal-title":"Front Cell Dev Biol"},{"key":"ref=445","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13229-018-0229-1","volume":"9","author":"Brown E.A.","year":"2018","unstructured":"Brown E.A.; Lautz J.D.; Davis T.R.; Gniffke E.P.; VanSchoiack A.A.W.; Neier S.C.; Tashbook N.; Nicolini C.; Fahnestock M.; Schrum A.G.; Smith S.E.P.; Clustering the autisms using glutamate synapse protein interaction networks from cortical and hippocampal tissue of seven mouse models. Mol Autism 2018,9(1),48","journal-title":"Mol Autism"},{"key":"ref=446","doi-asserted-by":"publisher","first-page":"592408","DOI":"10.3389\/fpsyt.2020.592408","volume":"11","author":"Arakawa H.","year":"2020","unstructured":"Arakawa H.; From multisensory assessment to functional interpretation of social behavioral phenotype in transgenic mouse models for autism spectrum disorders. Front Psychiatry 2020,11,592408","journal-title":"Front Psychiatry"},{"key":"ref=447","first-page":"140","volume":"8","author":"Pu\u015bcian A.","year":"2014","unstructured":"Pu\u015bcian A.; L\u0119ski S.; G\u00f3rkiewicz T.; Meyza K.; Lipp H.P.; Knapska E.; A novel automated behavioral test battery assessing cognitive rigidity in two genetic mouse models of autism. Front Behav Neurosci 2014,8,140","journal-title":"Front Behav Neurosci"},{"key":"ref=448","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13229-022-00521-6","volume":"13","author":"Jabarin R.","year":"2022","unstructured":"Jabarin R.; Netser S.; Wagner S.; Beyond the three-chamber test: Toward a multimodal and objective assessment of social behavior in rodents. Mol Autism 2022,13(1),41","journal-title":"Mol Autism"},{"key":"ref=449","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fnhum.2013.00417","volume":"7","author":"Argyropoulos A.","year":"2013","unstructured":"Argyropoulos A.; Gilby K.L.; Hill-Yardin E.L.; Studying autism in rodent models: reconciling endophenotypes with comorbidities. Front Hum Neurosci 2013,7,417","journal-title":"Front Hum Neurosci"},{"key":"ref=450","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13229-019-0263-7","volume":"10","author":"Das I.","year":"2019","unstructured":"Das I.; Estevez M.A.; Sarkar A.A.; Banerjee-Basu S.; A multifaceted approach for analyzing complex phenotypic data in rodent models of autism. Mol Autism 2019,10(1),11","journal-title":"Mol Autism"},{"key":"ref=451","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13072-015-0021-9","volume":"8","author":"Halsall J.A.","year":"2015","unstructured":"Halsall J.A.; Turan N.; Wiersma M.; Turner B.M.; Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response. Epigenetics Chromatin 2015,8(1),29","journal-title":"Epigenetics Chromatin"},{"key":"ref=452","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.neuron.2011.05.025","volume":"70","author":"Schaaf C.P.","year":"2011","unstructured":"Schaaf C.P.; Zoghbi H.Y.; Solving the autism puzzle a few pieces at a time. Neuron 2011,70(5),806-808","journal-title":"Neuron"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666231003121513","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/221624\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666231003121513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T12:09:25Z","timestamp":1704715765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/221624\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":452,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x22666231003121513","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}